+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 46972

Chapter 46972 contains a list of PDF Full Texts available from EurekaMag.

Carr, B.I.; Zajko, A.; Bron, K.; Orons, P.; Sammon, J.; Baron, R., 1997:
Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: interim analysis

Itoh, K.; Tsukamoto, E.; Kakizaki, H.; Nonomura, K.; Koyanagi, T.; Furudate, M.; Torizuka, K., 1993:
Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases

Twelves, C.; Campone, M.; Coudert, B.; Van den Bent, M.; de Jonge, M.; Dittrich, C.; Rampling, R.; Sorio, R.; Lacombe, D.; de Balincourt, C.; Fumoleau, P., 2002:
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme

Meropol, N.J.; Pazdur, R.; Vincent, M.; Willson, J.K.; Kelsen, D.P.; Douglass, H.O., 1996:
Phase II study of ZD1694 in patients with advanced gastric cancer

Planting, A.S.; de Wit, R.; van der Burg, M.E.; Stoter, G.; Verweij, J., 1996:
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma

Wagenaar, H.C.; Pecorelli, S.; Vergote, I.; Curran, D.; Wagener, D.J.; Kobierska, A.; Bolis, G.; Bokkel-Huinink, W.T.; Lacave, A.J.; Madronal, C.; Forn, M.; de Oliveira, C.F.; Mangioni, C.; Nooij, M.A.; Goupil, A.; Kerbrat, P.; Marth, C.H.; Tumolo, S.; Herben, M.G.; Zanaboni, F.; Vermorken, J.B., 2001:
Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer

Sugita, T.; Matsunaga, K.; Kobayashi, H.; Horikawa, S.; Suzuki, Y.; Nishiyama, H.; Maekawa, N.; Matsumoto, H.; Okazaki, M.; Katagami, N. , 1994:
Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer

Feliu, J.; Mel, R.; Borrega, P.; López Gómez, L.; Escudero, P.; Dorta, J.; Castro, J.; Vázquez-Estévez, S.E.; Bolaños, M.; Espinosa, E.; González Barón, M., 2002:
Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas

Shaughnessy, P.J.; Ornstein, D.; Ririe, D.; Callander, N.; Anderson, J.E.; Pollack, M.S.; Freytes, C.O.; Cruz, J.; Rodriquez, T.; Bachier, C.; LeMaistre, C.F., 2002:
Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience

Sakurai, M.; Ichiki, M.; Ohashi, Y.; Hayashi, I., 1993:
Phase II study of a novel combination regimen composed of cisplatin, carboplatin and etoposide against unresectable non-small cell lung cancer

Evans, W.K.; Earle, C.C.; Stewart, D.J.; Dahrouge, S.; Tomiak, E.; Goss, G.; Logan, D.; Goel, R.; Gertler, S.Z.; Dulude, H., 1997:
Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer

Planting, A.S.; van der Burg, M.E.; Goey, S.H.; Schellens, J.H.; van den Bent, M.J.; de Boer-Dennert, M.; Stoter, G.; Verweij, J., 1995:
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma

Hartung, G.; Hofheinz, R.D.; Wein, A.; Riedel, C.; Rost, A.; Fritze, D.; Kreuser, E.D.; Drees, M.; Kühnel, J.; Hehlmann, R.; Queisser, W., 2001:
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer

Yang, T.S.; Hsu, K.C.; Wang, H.M.; Lin, Y.C., 2002:
Phase II study of a weekly 8-hour 5-fluorouracil and leucovorin infusion for patients with advanced colorectal cancer: dose adjusted according to its toxicity

Athanasiadis, I.; Kies, M.S.; Miller, M.; Ganzenko, N.; Joob, A.; Marymont, M.; Rademaker, A.; Gradishar, W.J., 1995:
Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer

Westeel, V.; Jacoulet, P.; Breton, J.L.; Garnier, G.; Mercier, M.; Depierre, A., 1996:
Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience

Alberto, P., 1993:
Phase II study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancer

Brett, B.T.; Smith, S.C.; Bouvier, C.V.; Michaeli, D.; Hochhauser, D.; Davidson, B.R.; Kurzawinski, T.R.; Watkinson, A.F.; Van Someren, N.; Pounder, R.E.; Caplin, M.E., 2002:
Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer

Borner, M.M.; Dietrich, D.; Stupp, R.; Morant, R.; Honegger, H.; Wernli, M.; Herrmann, R.; Pestalozzi, B.C.; Saletti, P.; Hanselmann, S.; Müller, S.; Brauchli, P.; Castiglione-Gertsch, M.; Goldhirsch, A.; Roth, A.D., 2002:
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer

Kim, T.W.; Kang, Y.K.; Ahn, J.H.; Chang, H.M.; Yook, J.H.; Oh, S.T.; Kim, B.S.; Lee, J.S., 2002:
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer

Vieitez, J.M.; Valladares, M.; Gracia, M.; Gonzalez-Barón, M.; Martín, G.; Mel, J.R.; Rodríguez, R.; Constenla, M.; Gómez Aldavarí, J.L.; Domínguez, S.; Dorta, J.; García-Girón, C.; López, R.; Sevilla, I.; Esteban, E.; Antón, L.M.; Peláez, I.; López, E.; Lacave, A.J., 2002:
Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Falk, S.J.; Maughan, T.S.; Laurence, V.M.; Lamont, A.; Boote, D.; Ford, J.M.; Osborne, R.J.; Bleehen, N.M., 1993:
Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer

Gururangan, S.; Cavazos, C.M.; Ashley, D.; Herndon, J.E.; Bruggers, C.S.; Moghrabi, A.; Scarcella, D.L.; Watral, M.; Tourt-Uhlig, S.; Reardon, D.; Friedman, H.S., 2002:
Phase II study of carboplatin in children with progressive low-grade gliomas

Rougier, P.; Zarba, J.J.; Ducreux, M.; Basile, M.; Pignon, J.P.; Mahjoubi, M.; Benahmed, M.; Droz, J.P.; Cvitkovic, E.; Armand, J.P., 1993:
Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma

Feliu, J.; González Barón, M.; García Girón, C.; Espinosa, E.; Vicent, J.M.; Gómez Navarro, J.; Berrocal, A.; Ordóñez, A.; Vilches, Y.; de Castro, J.; Díaz, J., 1996:
Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, Spain

Sakurai, M.; Ichiki, M.; Hayashi, I., 1997:
Phase II study of combination chemotherapy with cisplatin, carboplatin and etoposide (CPVP) in unresectable non-small cell lung cancer: analysis of survival time and prognostic factors

Rosenthal, M.A.; Gruber, M.L.; Glass, J.; Nirenberg, A.; Finlay, J.; Hochster, H.; Muggia, F.M., 2000:
Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme

Nakata, Y.; Yamada, T.; Itoh, R.; Koishi, K.; Hiraoka, K.; Yamagami, K.; Itani, Y.; Toyoda, S.; Itoh, K.; Kimura, T.; Hosokawa, K.; Honjo, H.; Fujita, H.; Koshiba, H.; Hara, Y.; Tsuchiya, H.; Adachi, S., 2002:
Phase II study of combination therapy with paclitaxel and carboplatin against postoperative small residual disease in patients with stage I c-IV ovarian cancer--KCOG 989 trial

Hauns, B.; Häring, B.; Köhler, S.; Mross, K.; Unger, C., 2001:
Phase II study of combined 5-fluorouracil/ Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer

Mori, K.; Kamiyama, Y.; Kondoh, T.; Tominaga, K., 2002 :
Phase II study of combined Vinorelbine (Navelbine) plus cisplatin for advanced non-small cell lung cancer (an interim report)

Kubota, K.; Tamura, T.; Fukuoka, M.; Furuse, K.; Ikegami, H.; Ariyoshi, Y.; Kurita, Y.; Saijo, N., 2000:
Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902

Hartmann, J.T.; Kanz, L.; Bokemeyer, C., 2000:
Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma

Lopez, M.; Carpano, S.; Cancrini, A.; Marcellini, M.; Del Medico, P.; Rinaldi, M.; Vici, P.; Paoletti, G.; Di Lauro, L., 1993:
Phase II study of continuous intravenous infusion of recombinant interleukin-2 in patients with advanced renal cell carcinoma

Palumbo, R.; Palmeri, S.; Antimi, M.; Gatti, C.; Raffo, P.; Villani, G.; Toma, S., 1998:
Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas

Warner, E.; Hedley, D.; Andrulis, I.; Myers, R.; Trudeau, M.; Warr, D.; Pritchard, K.I.; Blackstein, M.; Goss, P.E.; Franssen, E.; Roche, K.; Knight, S.; Webster, S.; Fraser, R.A.; Oldfield, S.; Hill, W.; Kates, R., 1998:
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen

Stopeck, A.T.; Jones, A.; Hersh, E.M.; Thompson, J.A.; Finucane, D.M.; Gutheil, J.C.; Gonzalez, R., 2001:
Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma

Latreille, J.; Cormier, Y.; Martins, H.; Goss, G.; Fisher, B.; Eisenhauer, E.A., 1996:
Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer

Niho, S.; Ohe, Y.; Kakinuma, R.; Kubota, K.; Matsumoto, T.; Ohmatsu, H.; Goto, K.; Nishiwaki, Y., 2002:
Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer

Kim, Y.H.; Kim, J.S.; Choi, Y.H.; In, K.H.; Park, H.S.; Hong, D.S.; Jeong, T.J.; Lee, Y.Y.; Nam, E.; Lee, S.N.; Lee, K.S.; Kim, H.K., 2002:
Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer

Specht, L.; Larsen, S.K.; Hansen, H.S., 2000:
Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck

Amodio, A.; Carpano, S.; Paoletti, G.; Gionfra, T.; Rinaldi, M.; Manfredi, C.; Foggi, P.; Lopez, M., 1998:
Phase II study of docetaxel in patients with advanced stage soft tissue sarcoma

Kavanagh, J.J.; Kudelka, A.P.; de Leon, C.G.; Tresukosol, D.; Hord, M.; Finnegan, M.B.; Kim, E.E.; Varma, D.; Forman, A.; Cohen, P.; Edwards, C.L.; Freedman, R.S.; Verschraegen, C.F., 1996:
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum

Coleman, R.E.; Howell, A.; Eggleton, S.P.; Maling, S.J.; Miles, D.W., 2000:
Phase II study of docetaxel in patients with liver metastases from breast cancer. UK study group

Mattson, K.; Bosquee, L.; Dabouis, G.; Le Groumellec, A.; Pujol, J.L.; Marien, S.; Stupp, R.; Douillard, J.Y.; Brägas, B.; Berille, J.; Olivares, R.; Le Chevalier, T., 2000:
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice

Savarese, D.M.; Halabi, S.; Hars, V.; Akerley, W.L.; Taplin, M.E.; Godley, P.A.; Hussain, A.; Small, E.J.; Vogelzang, N.J., 2001:
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B

Krug, L.M.; Miller, V.A.; Kalemkerian, G.P.; Kraut, M.J.; Ng, K.K.; Heelan, R.T.; Pizzo, B.A.; Perez, W.; McClean, N.; Kris, M.G., 2000:
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer

Vaishampayan, U.; Glode, M.; Du, W.; Kraft, A.; Hudes, G.; Wright, J.; Hussain, M., 2000:
Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma

Meredith, R.F.; Khazaeli, M.B.; Plott, W.E.; Grizzle, W.E.; Liu, T.; Schlom, J.; Russell, C.D.; Wheeler, R.H.; LoBuglio, A.F., 1996:
Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer

Kobayashi, H.; Kawai, S.; Sakayori, S.; Kaneko, M.; Ito, Y.; Ujike, Y.; Kobayashi, K.; Imaizumi, H.; Hoshi, S.; Endo, S., 1994:
Phase II study of edobacomab (E5) in the treatment of gram-negative sepsis

Nisticò, C.; Garufi, C.; Barni, S.; Frontini, L.; Gallà, D.A.; Giannarelli, D.; Vaccaro, A.; D'Ottavio, A.M.; Terzoli, E., 1999:
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancer

Parnis, F.X.; Olver, I.N.; Kotasek, D.; Norman, J.; Taylor, A.; Russell, J.; Patterson, K.; Keefe, D.; Marafioti, T., 2000:
Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site

Cripps, C.; Burnell, M.; Jolivet, J.; Batist, G.; Lofters, W.; Dancey, J.; Iglesias, J.; Fisher, B.; Eisenhauer, E.A., 1999:
Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study

Tsimberidou, A.M.; O'Brien, S.M.; Cortes, J.E.; Faderl, S.; Andreeff, M.; Kantarjian, H.M.; Keating, M.J.; Giles, F.J., 2002:
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders

Epelbaum, R.; Rosenblatt, E.; Nasrallah, S.; Faraggi, D.; Gaitini, D.; Mizrahi, S.; Kuten, A., 2002:
Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer

von Minckwitz, G.; Bauknecht, T.; Visseren-Grul, C.M.; Neijt, J.P., 1999:
Phase II study of gemcitabine in ovarian cancer

Sekine, I.; Nishiwaki, Y.; Kakinuma, R.; Kubota, K.; Hojo, F.; Matsumoto, T.; Ohmatsu, H.; Yokozaki, M.; Goto, K.; Miyamoto, T.; Takafuji, J.; Kodama, T., 1997:
Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis--JCOG study 9413

Novello, S.; Galli, L.; Antonuzzo, A.; Crinó, L.; Pozzi, E.; Selvaggi, G.; Ricci, S.; Marrocolo, F.; Darwish, S.; Sorbolini, S.; Tonato, M.; Scagliotti, G.V., 2001:
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer

Wilailak, S.; Tresukosol, D.; Linasmita, V.; Termrungruanglert, W., 2001:
Phase II study of high-dose paclitaxel in platinum-refractory epithelial ovarian cancer

Marschke, R.F.; Grill, J.P.; Sloan, J.A.; Wender, D.B.; Levitt, R.; Mailliard, J.A.; Gerstner, J.B.; Ghosh, C.; Morton, R.F.; Jett, J.R., 1999:
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer

Ali, M.A.; Kraut, M.J.; Valdivieso, M.; Herskovic, A.M.; Du, W.; Kalemkerian, G.P., 1998:
Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer

Thongprasert, S., 2000:
Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer

Lichtman, S.M.; Niedzwiecki, D.; Barcos, M.; Carlisle, T.L.; Cooper, M.R.; Johnson, J.L.; Peterson, B.A., 2000:
Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B

Gridelli, C.; Perrone, F.; D'Aprile, M.; Rossi, A.; Palmeri, S.; Curcio, C.; Veltri, E.; Ianniello, G.; Lorusso, V.; Palmieri, G., 1995:
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer

Meredith, R.F.; Khazaeli, M.B.; Macey, D.J.; Grizzle, W.E.; Mayo, M.; Schlom, J.; Russell, C.D.; LoBuglio, A.F., 1999:
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer

Baars, J.W.; Wagstaff, J.; Van Groeningen, C.J.; Vermorken, J.B.; Bijvank, E.M.; Pinedo, H.M.; Nauta, J.J., 1993:
Phase II study of interferon-gamma and interleukin-2: tachyphylaxis of toxicity to the liver during increasing immune enhancement

Lümmen, G.; Goepel, M.; Möllhoff, S.; Hinke, A.; Otto, T.; Rübben, H., 1996:
Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma

Vlasveld, L.T.; Horenblas, S.; Hekman, A.; Hilton, A.M.; Dubbelman, A.C.; Melief, C.J.; Rankin, E.M., 1994:
Phase II study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancer

Dropcho, E.J.; Rosenfeld, S.S.; Vitek, J.; Guthrie, B.L.; Morawetz, R.B., 1998:
Phase II study of intracarotid or selective intracerebral infusion of cisplatin for treatment of recurrent anaplastic gliomas

Hoff, P.M.; Ellerton, J.A.; Dakhil, S.R.; Winn, R.J.; Abbruzzese, J.L.; Pazdur, R., 2001:
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinoma

Verschraegen, C.F.; Levenback, C.; Vincent, M.; Wolf, J.; Bevers, M.; Loyer, E.; Kudelka, A.P.; Kavanagh, J.J., 2001:
Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan

Oh, Y.; Perez-Soler, R.; Fossella, F.V.; Glisson, B.S.; Kurie, J.; Walsh, G.L.; Truong, M.; Shin, D.M., 2000:
Phase II study of intravenous Doxil in malignant pleural mesothelioma

Case, D.C.; Gerber, M.C.; Gams, R.A.; Crawford, J.; Votaw, M.L.; Higano, C.S.; Pruitt, B.T.; Gould, J., 1993:
Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma

Watanabe, N.; Miyagawa, I.; Higasibori, Y.; Nakahara, T.; Sumi, F.; Ishida, G.; Abe, B.; Inoue, A.; Hanamoto, N., 1994:
Phase II study of intravesical chemoprophylaxis of epirubicin after transurethral resection of bladder tumors. Tottori University Oncology Group

Turner, C.D.; Gururangan, S.; Eastwood, J.; Bottom, K.; Watral, M.; Beason, R.; McLendon, R.E.; Friedman, A.H.; Tourt-Uhlig, S.; Miller, L.L.; Friedman, H.S., 2002:
Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience

Takeda, K.; Takifuji, N.; Uejima, H.; Yoshimura, N.; Terakawa, K.; Negoro, S., 2002:
Phase II study of irinotecan and carboplatin for advanced non-small cell lung cancer

Kudoh, S.; Fujiwara, Y.; Takada, Y.; Yamamoto, H.; Kinoshita, A.; Ariyoshi, Y.; Furuse, K.; Fukuoka, M., 1998:
Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group

Furukawa, H.; Hiratsuka, M.; Imaoka, S.; Ishikawa, O.; Kabuto, T.; Sasaki, Y.; Kameyama, M.; Ohigashi, H.; Nakano, H.; Yasuda, T.; Murata, K., 1999:
Phase II study of limited surgery for early gastric cancer: segmental gastric resection

Verweij, J.; Judson, I.; Steward, W.; Coleman, R.; Woll, P.; van Pottelsberghe, C.; van Glabbeke, M.; Mouridsen, H., 1994 :
Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group study

Stewart, D.J.; Eapen, L.; Girard, A.; Verma, S.; Genest, P.; Evans, W.K., 1993:
Phase II study of lonidamine plus radiotherapy in the treatment of brain metastases

Smorenburg, C.H.; Seynaeve, C.; Bontenbal, M.; Planting, A.S.; Sindermann, H.; Verweij, J., 2001:
Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients

Wiernik, P.H.; Moore, D.F.; Bennett, J.M.; Vogl, S.E.; Harris, J.E.; Luger, S.; Oken, M.M.; Glick, J.H., 1998:
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481)

Kikuyama, S.; Inada, T.; Oyama, R.; Ogata, Y., 2003:
Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer

Pusztai, L.; Holmes, F.A.; Fraschini, G.; Hortobagyi, G.N., 1999:
Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy

Mammoliti, S.; Merlini, L.; Caroti, C.; Gallo, L., 1996:
Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients

Grossi, F.; Pennucci, M.C.; Serrano, J.; Frola, C.; Mereu, C.; Scolaro, T.; Ratto, G.B.; Tixi, L.; Ardizzoni, A., 2003:
Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancer

Buzaid, A.C.; Colome, M.; Bedikian, A.; Eton, O.; Legha, S.S.; Papadopoulos, N.; Plager, C.; Ross, M.; Lee, J.E.; Mansfield, P.; Rice, J.; Ring, S.; Lee, J.J.; Strom, E.; Benjamin, R., 1999:
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases

Pujol, J.L.; Monnier, A.; Berille, J.; Cerrina, M.L.; Douillard, J.Y.; Rivière, A.; Grandgirard, A.; Gouva, S.; Bizzari, J.P.; Le Chevalier, T., 1994:
Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer

van der Gaast, A.; Henzen-Logmans, S.C.; Planting, A.S.; Stoter, G.; Verweij, J., 1993:
Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary site

Cartwright, T.H.; Cohn, A.; Varkey, J.A.; Chen, Y-Miao.; Szatrowski, T.P.; Cox, J.V.; Schulz, J.J., 2002:
Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer

Lin, J.K.; Wang, W.S.; Hsieh, R.K.; Hsu, T.C.; Chiou, T.J.; Liu, J.H.; Fan, F.S.; Yen, C.C.; Lin, T.C.; Jiang, J.K.; Yang, S.H.; Wang, H.S.; Chen, P.M., 2001:
Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience

White, S.C.; Cheeseman, S.; Thatcher, N.; Anderson, H.; Carrington, B.; Hearn, S.; Ross, G.; Ranson, M., 2000:
Phase II study of oral topotecan in advanced non-small cell lung cancer

Freyer, G.; Delozier, T.; Lichinister, M.; Gedouin, D.; Bougnoux, P.; His, P.; Imadalou, K.; Trillet-Lenoir, V., 2002:
Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy

Zelek, L.; Cottu, P.; Tubiana-Hulin, M.; Vannetzel, J-M.; Chollet, P.; Misset, J-L.; Chouaki, N.; Marty, M.; Gamelin, E.; Culine, S.; Dieras, V.; Mackenzie, S.; Spielmann, M., 2002:
Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients

Monnet, I.; Brienza, S.; Hugret, F.; Voisin, S.; Gastiaburu, J.; Saltiel, J.C.; Soulié, P.; Armand, J.P.; Cvitkovic, E.; de Cremoux, H., 1998:
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques

Louvet, C.; André, T.; Tigaud, J.M.; Gamelin, E.; Douillard, J.Y.; Brunet, R.; François, E.; Jacob, J.H.; Levoir, D.; Taamma, A.; Rougier, P.; Cvitkovic, E.; de Gramont, A., 2002:
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

Noda, K.; Ikeda, M.; Kudo, R.; Nishiya, I.; Yajima, A.; Tanaka, K.; Kodama, S.; Takahashi, T.; Tokunaga, A.; Satoh, I.; Nozawa, S.; Taketani, Y.; Terashima, Y.; Isonishi, S.; Takeda, Y.; Nishijima, M.; Kuroshima, Y.; Fujii, S.; Izumi, R.; Tamaya, T.; Mori, T.; Okada, H.; Ogita, S.; Ozaki, M.; Hatae, M., 1996:
Phase II study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion

Chen, C-Hung.; Chang, W-Cheng.; Lin, M-Chin.; Hsu, J-Wen.; Chao, T-Yi.; Tsao, T.C.Y., 2002:
Phase II study of paclitaxel (Genaxol) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC)

Thongprasert, S., 1998:
Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer

Laohavinij, S.; Maoleekoonpairoj, S.; Cheirsilpa, A.; Maneechavakajorn, J.; Sirachainant, E.; Arpornvivat, W.; Jaisathaporn, K.; Ratanatharathorn, V., 1999:
Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer

Lück, H.J.; Thomssen, C.; du Bois, A.; Untch, M.; Lisboa, B.; Köhler, G.; Diergarten, K., 1997:
Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer

Boyer, M.J.; Mitchell, P.; Goldstein, D.; Millward, M.J.; Olver, I.N.; Clarke, S.J.; Richardson, G.; Davis, I., 2001:
Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer

Lissoni, A.; Zanetta, G.; Losa, G.; Gabriele, A.; Parma, G.; Mangioni, C., 1996 :
Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer

Rivera, E.; Holmes, F.A.; Frye, D.; Valero, V.; Theriault, R.L.; Booser, D.; Walters, R.; Buzdar, A.U.; Dhingra, K.; Fraschini, G.; Hortobagyi, G.N., 2001:
Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy

Bokemeyer, C.; Beyer, J.; Metzner, B.; Ruther, U.; Harstrick, A.; Weissbach, L.; Kohrmann, U.; Verbeek, W.; Schmoll, H.J., 1996:
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer

Yamaguchi, K.; Tada, M.; Horikoshi, N.; Otani, T.; Takiuchi, H.; Saitoh, S.; Kanamaru, R.; Kasai, Y.; Koizumi, W.; Sakata, Y.; Taguchi, T., 2002:
Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer

Harrington, K.J.; Lewanski, C.; Northcote, A.D.; Whittaker, J.; Peters, A.M.; Vile, R.G.; Stewart, J.S., 2001:
Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck

Samantas, E.; Kalofonos, H.; Linardou, H.; Nicolaides, C.; Mylonakis, N.; Fountzilas, G.; Kosmidis, P.; Skarlos, D., 2001:
Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study

de Wit, R.; van der Burg, M.E.; van den Gaast, A.; Logmans, A.; Stoter, G.; Verweij, J., 1994:
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy

Kavanagh, J.J..; Tresukosol, D..; De Leon, C..Gonzalez.; Edwards, C.L..; Freedman, R.S..; Hord, M..; Howell, E..; Lenzi, R..; Krakoff, I.H..; Kudelka, A.P.., 1995:
Phase II study of prolonged oral etoposide in refractory ovarian cancer

Fulton, D.; Urtasun, R.; Forsyth, P., 1996:
Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma

de Vries, M.J.; Schilder, J.N.; Mulder, C.L.; Vrancken, A.M.; Remie, M.; Garssen, B., 1997:
Phase II study of psychotherapeutic intervention in advanced cancer

Blay, J.Y.; Judson, I.; Rodenhuis, S.; Hermans, C.; Smith, M.; van Glabbeke, M.; Verweij, J., 2000:
Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens

Sato, A.; Kurihara, M.; Horikoshi, N.; Aiba, K.; Kikkawa, N.; Shirouzu, K.; Mitachi, Y.; Sakata, Y.; Wakui, A., 1999:
Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group

Walters, R.S.; Theriault, R.L.; Booser, D.J.; Esparza, L.; Hortobagyi, G.N., 1995:
Phase II study of recombinant alpha-interferon (rIFN alpha) and continuous-infusion 5-fluorouracil in metastatic breast cancer

Worth, L.L.; Jaffe, N.; Benjamin, R.S.; Papadopoulos, N.E.; Patel, S.; Raymond, A.K.; Jia, S.F.; Rodriguez, C.; Gano, J.; Gianan, M.A.; Kleinerman, E.S., 1998:
Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma

Chen, S.C.; Lin, M.C.; Chang, J.W.; Wang, S.W.; Lee, C.H.; Tsao, T.C., 2001:
Phase II study of regimen of gemcitabine and cisplatin in advanced non-small cell lung cancer

Verweij, J.; Wanders, J.; Gil, T.; Schöffski, P.; Catimel, G.; te Velde, A.; de Mulder, P.H., 1996:
Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group

Roelofs, E.J.; Wagener, D.J.; Conroy, T.; Wils, J.; Burghouts, J.T.; Fickers, M.; de Graeff, A.; Lalisang, F.; Paillot, B., 1993:
Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer

Takahashi, S.; Kinoshita, T.; Konishi, M.; Nakagouri, T.; Inoue, K.; Ono, M.; Sugitou, M.; Ohtsu, A.; Boku, N.; Yoshida, S., 2002:
Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer

Crump, M.; Couban, S.; Meyer, R.; Rudinskas, L.; Zanke, B.; Gluck, S.; Maksymiuk, A.; Hoskins, P.; Matthews, S.; Eisenhauer, E., 2002:
Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study

Belch, A.R.; Eisenhauer, E.A.; Muldal, A.; Browman, G.; Klasa, R.; Osterwalder, B., 1995:
Phase II study of subcutaneous rHu-interleukin-2 and rHu-interferon alpha-2a in previously treated patients with multiple myeloma

Dawson, N.; Figg, W.D.; Brawley, O.W.; Bergan, R.; Cooper, M.R.; Senderowicz, A.; Headlee, D.; Steinberg, S.M.; Sutherland, M.; Patronas, N.; Sausville, E.; Linehan, W.M.; Reed, E.; Sartor, O., 1998:
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal

Chen, Y.; Perng, R.P.; Yang, K.Y.; Lin, W.C.; Wu, H.W.; Tsai, C.M.; Whang-Peng, J., 2000:
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy

Christodoulou, C.; Bafaloukos, D.; Kosmidis, P.; Samantas, E.; Bamias, A.; Papakostas, P.; Karabelis, A.; Bacoyiannis, C.; Skarlos, D.V., 2001:
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

Marx, G.M.; Pavlakis, N.; McCowatt, S.; Boyle, F.M.; Levi, J.A.; Bell, D.R.; Cook, R.; Biggs, M.; Little, N.; Wheeler, H.R., 2002:
Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme

Clerici, M.; De Marinis, F.; Piazza, E.; Frontini, L.; Tucci, E.; Barni, S.; Bretti, S.; Luporini, G.; Intini, C., 1999:
Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer

ten Bokkel Huinink, W.W.; van Warmerdam, L.J.; Helmerhorst, T.J.; Schaefers, M.C.; Beijnen, J.H.; Rodenhuis, S., 1997:
Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancer

Miller, V.A.; Ng, K.K.; Grant, S.C.; Kindler, H.; Pizzo, B.; Heelan, R.T.; von Roemeling, R.; Kris, M.G., 1998:
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer

Miller, K.D.; Picus, J.; Blanke, C.; John, W.; Clark, J.; Shulman, L.N.; Thornton, D.; Rowinsky, E.; Loehrer, P.J., 2000:
Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer

Stewart, D.J.; Eisenhauer, E.; Macdonald, D.R.; Cairncross, J.G.; Langleben, A., 1993:
Phase II study of tiazofurin in gliomas in adults. A National Cancer Institute of Canada study

Bramwell, V.H.; Eisenhauer, E.A.; Blackstein, M.; Boos, G.; Knowling, M.; Jolivet, J.; Bogues, W., 1995:
Phase II study of topotecan (NSC 609 699) in patients with recurrent or metastatic soft tissue sarcoma

Macdonald, D.; Cairncross, G.; Stewart, D.; Forsyth, P.; Sawka, C.; Wainman, N.; Eisenhauer, E., 1996:
Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group

Giles, F.J.; Garcia-Manero, G.; Cortes, J.E.; Baker, S.D.; Miller, C.B.; O'Brien, S.M.; Thomas, D.A.; Andreeff, M.; Bivins, C.; Jolivet, J.; Kantarjian, H.M., 2002:
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia

Sekine, I.; Nishiwaki, Y.; Ogino, T.; Yokoyama, A.; Saito, M.; Mori, K.; Tsukiyama, I.; Tsuchiya, S.; Hayakawa, K.; Yoshimura, K.; Ishizuka, N.; Saijo, N., 2002:
Phase II study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindesine for unresectable stage III non-small-cell lung cancer: Japan Clinical Oncology Group Study 9306

Vermorken, J..B..; Mangioni, C..; Pecorelli, S..; Van Der Burg, M..E..L..; Van Oosterom, A..T..; Ten Bokkel Huinink, W..W..; Rotmensz, N..; Dalesio, O.., 2001:
Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix

Jassem, J.; Karnicka-Młodkowska, H.; van Pottelsberghe, C.; van Glabbeke, M.; Noseda, M.A.; Ardizzoni, A.; Gozzelino, F.; Planting, A.; van Zandwijk, N., 1993:
Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group

Isokangas, O.P.; Knuuttila, A.; Halme, M.; Mäntylä, M.; Lindström, I.; Nikkanen, V.; Viren, M.; Joensuu, H.; Mattson, K., 1999:
Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer

Furuse, K.; Kubota, K.; Kawahara, M.; Takada, M.; Kimura, I.; Fujii, M.; Ohta, M.; Hasegawa, K.; Yoshida, K.; Nakajima, S.; Ogura, T.; Niitani, H., 1996:
Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group

Oudard, S.; Caty, A.; Humblet, Y.; Beauduin, M.; Suc, E.; Piccart, M.; Rolland, F.; Fumoleau, P.; Bugat, R.; Houyau, P.; Monnier, A.; Sun, X.; Montcuquet, P.; Breza, J.; Novak, J.; Gil, T.; Chopin, D., 2001:
Phase II study of vinorelbine in patients with androgen-independent prostate cancer

Baldini, E.; Tibaldi, C.; Chella, A.; Angeletti, C.A.; Silvano, G.; Andrei, A.; Algeri, R.; Conte, P.F., 1996:
Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer

Goss, P.E.; Clark, R.M.; Ambus, U.; Weizel, H.A.; Wadden, N.A.; Crump, M.; Walde, D.; Tye, L.M.; De Coster, R.; Bruynseels, J., 1995:
Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen

Lorenz, M.; Mueller, H.H.; Mattes, E.; Gassel, H.J.; Junginger, T.; Saeger, H.D.; Schramm, H.; Staib-Sebler, E.; Vetter, G.; Heinrich, S.; Köhne, C.H., 2001:
Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas

Esteva, F.J.; Valero, V.; Booser, D.; Guerra, L.T.; Murray, J.L.; Pusztai, L.; Cristofanilli, M.; Arun, B.; Esmaeli, B.; Fritsche, H.A.; Sneige, N.; Smith, T.L.; Hortobagyi, G.N., 2002:
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer

Aihara, T.; Kim, Y.; Takatsuka, Y., 2002:
Phase II study of weekly docetaxel in patients with metastatic breast cancer

Beer, T.M.; Pierce, W.C.; Lowe, B.A.; Henner, W.D., 2001:
Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer

van den Bent, M.J.; Pronk, L.; Sillevis Smitt, P.A.; Vecht, C.J.; Eskens, F.A.; Verweij, J., 1999:
Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma

Baselga, J.; Tripathy, D.; Mendelsohn, J.; Baughman, S.; Benz, C.C.; Dantis, L.; Sklarin, N.T.; Seidman, A.D.; Hudis, C.A.; Moore, J.; Rosen, P.P.; Twaddell, T.; Henderson, I.C.; Norton, L., 1999:
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer

Naka, N.; Kawahara, M.; Okishio, K.; Hosoe, S.; Ogawara, M.; Atagi, S.; Takemoto, Y.; Ueno, K.; Kawaguchi, T.; Tsuchiyama, T.; Furuse, K., 2002:
Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer

Aghajanian, C.; Fennelly, D.; Shapiro, F.; Waltzman, R.; Almadrones, L.; O'Flaherty, C.; O'Conner, K.; Venkatraman, E.; Barakat, R.; Curtin, J.; Brown, C.; Reich, L.; Wuest, D.; Norton, L.; Hoskins, W.; Spriggs, D.R., 1998:
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer

Verweij, J.; de Mulder, P.H.; de Graeff, A.; Vermorken, J.B.; Wildiers, J.; Kerger, J.; Schornagel, J.; Cognetti, F.; Kirkpatrick, A.; Sahmoud, T.; Lefebvre, J.L., 1996:
Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group

Rau, B.; Wust, P.; Gellermann, J.; Tilly, W.; Hünerbein, M.; Löffel, J.; Stahl, H.; Riess, H.; Budach, V.; Felix, R.; Schlag, P., 1998:
Phase II study on preoperative radio-chemo-thermotherapy in locally advanced rectal carcinoma

van Hoesel, Q.G.; Verweij, J.; Catimel, G.; Clavel, M.; Kerbrat, P.; van Oosterom, A.T.; Kerger, J.; Tursz, T.; van Glabbeke, M.; van Pottelsberghe, C., 1994:
Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group

Chen, Y.M.; Perng, R.P.; Whang-Peng, J.; Wu, H.W.; Lin, W.C.; Tsai, C.M., 2001:
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer

Villar-Grimalt, A.; Aranda, E.; Massutí, B.; Belón, J.; Antón, A.; Jimeno, J.M.; Candel, M.T.; García de Paredes, M.L.; Colajori, E., 1994:
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society)

Maoleekoonpairoj, S.; Phromratanapongse, P.; Puttanuparp, S., 1998:
Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma

Fletcher, J.L., 2002:
Phase II temporomandibular joint disorder treatment

Kucuk, O.; Young, M.L.; Habermann, T.M.; Wolf, B.C.; Jimeno, J.; Cassileth, P.A., 2000:
Phase II trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study

Esteva, F.J.; Soh, L.T.; Holmes, F.A.; Plunkett, W.; Meyers, C.A.; Forman, A.D.; Hortobagyi, G.N., 2000:
Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer

Antón, A.; Díaz-Fernández, N.; González Larriba, J.L.; Vadell, C.; Masutti, B.; Montalar, J.; Barneto, I.; Artal, A.; Rosell, R., 1999:
Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)

Hasbini, A.; Mahjoubi, R.; Fandi, A.; Chouaki, N.; Taamma, A.; Lianes, P.; Cortès-Funes, H.; Alonso, S.; Armand, J.P.; Cvitkovic, E.; Raymond, E., 1999:
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type

Hsu, C.; Huang, C-Sheng.; Chao, T-Yi.; Lu, Y-Shen.; Bu, C-Fang.; Chen, M.M.; Chang, K-Jeng.; Cheng, A-Lii., 2002:
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma

Jeanfaivre, T.; Souday, V.; Chaleil, D.; Maillet, F.; Tuchais, E., 2000:
Phase II trial evaluating the effect of megestrol acetate-prednisolone combination in the treatment of anorexia during the palliative-care phase of lung cancer

Guastalla, J.P.; Vermorken, J.B.; Wils, J.A.; George, M.; Scotto, V.; Nooij, M.; ten Bokkel Huinnink, W.W.; Dalesio, O.; Renard, J., 1994:
Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Group

Jiao, X.; Liu, G.Y.; Shan, C.O.; Zhao, X.; Li, X.W.; Gathmann, I.; Royce, C., 1998:
Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria

Cascinu, S.; Del Ferro, E.; Ligi, M.; Graziano, F.; Castellani, A.; Catalano, G., 1996:
Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy

Arnold, A.; Ayoub, J.; Douglas, L.; Hoogendoorn, P.; Skingley, L.; Gelmon, K.; Hirsh, V.; Eisenhauer, E., 1994:
Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

Rothenberg, M.L.; Benedetti, J.K.; Macdonald, J.S.; Seay, T.E.; Neubauer, M.A.; George, C.S.; Tanaka, M.S.; Giguere, J.K.; Pruitt, B.T.; Abbruzzese, J.L., 2002:
Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study

Ravandi, F.; Rytting, M.E.; Osmon, C.; Braud, E.L.; Roach, R.W.; Edwards, K.; Winn, R.; Abbruzzese, J.L.; Pazdur, R., 2000:
Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer

André, T.; Lotz, J.P.; Bouleuc, C.; Azzouzi, K.; Houry, S.; Hannoun, L.; See, J.; Esteso, A.; Avenin, D.; Izrael, V., 1996:
Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma

Pazdur, R.; Medgyesy, D.C.; Winn, R.J.; Dakhil, S.R.; Moore, D.F.; Scalzo, A.; Hoff, P.M.; Arbuck, S.G.; Abbruzzese, J.L., 1999:
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma

Whitehead, R.P.; Unger, J.M.; Flaherty, L.E.; Eckardt, J.R.; Taylor, S.A.; Didolkar, M.S.; Samlowski, W.; Sondak, V.K., 2001:
Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy. A Southwest Oncology Group study

Celik, I.; Kars, A.; Güler, N.; Barişta, I.; Tekuzman, G.; Ozyilkan, O.; Hayran, M.; Firat, D., 1998:
Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas

Khoo, K.; Brandes, L.; Reyno, L.; Arnold, A.; Dent, S.; Vandenberg, T.; Lebwohl, D.; Fisher, B.; Eisenhauer, E., 1999:
Phase II trial of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine.HCl and doxorubicin chemotherapy in metastatic breast cancer: A National Cancer Institute of Canada clinical trials group study

Brown, K.S.; Levitt, D.J.; Shannon, M.; Link, B.K., 2002:
Phase II trial of Remitogen (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphoma

Pazdur, R.; Meropol, N.J.; Casper, E.S.; Fuchs, C.; Douglass, H.O.; Vincent, M.; Abbruzzese, J.L., 1996:
Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancer

Tan, E.H.; Khoo, K.S.; Wee, J.; Fong, K.W.; Lee, K.S.; Lee, K.M.; Chua, E.T.; Tan, T.; Khoo-Tan, H.S.; Yang, T.L.; Au, E.; Tao, M.; Ong, Y.K.; Chua, E.J., 1999:
Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma

Kris, M.G.; Clark, R.A.; Tyson, L.B.; Hahne, W.F.; Pisters, K.M.; Gralla, R.J., 1993:
Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2

Mikulski, S.M.; Costanzi, J.J.; Vogelzang, N.J.; McCachren, S.; Taub, R.N.; Chun, H.; Mittelman, A.; Panella, T.; Puccio, C.; Fine, R.; Shogen, K., 2002:
Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma

Ellerhorst, J.A.; Tu, S.M.; Amato, R.J.; Finn, L.; Millikan, R.E.; Pagliaro, L.C.; Jackson, A.; Logothetis, C.J., 1998:
Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer

Louvet, C.; André, T.; Hammel, P.; Selle, F.; Landi, B.; Cattan, S.; Fonck, M.; Flesch, M.; Colin, P.; Balosso, J.; Ruszniewski, P.; de Gramont, A., 2001:
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)

Stathopoulos, G.P.; Rigatos, S.K.; Pergantas, N.; Tsavdarides, D.; Athanasiadis, I.; Malamos, N.A.; Stathopoulos, J.G., 2002:
Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer

Motzer, R.J.; Rakhit, A.; Thompson, J.; Gurney, H.; Selby, P.; Figlin, R.; Negrier, S.; Ernst, S.; Siebels, M.; Ginsberg, M.; Rittweger, K.; Hooftman, L., 2002:
Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma

Varterasian, M.L.; Mohammad, R.M.; Shurafa, M.S.; Hulburd, K.; Pemberton, P.A.; Rodriguez, D.H.; Spadoni, V.; Eilender, D.S.; Murgo, A.; Wall, N.; Dan, M.; Al-Katib, A.M., 2000:
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia

Quinn, J.A.; Pluda, J.; Dolan, M.Eileen.; Delaney, S.; Kaplan, R.; Rich, J.N.; Friedman, A.H.; Reardon, D.A.; Sampson, J.H.; Colvin, O.Michael.; Haglund, M.M.; Pegg, A.E.; Moschel, R.C.; McLendon, R.E.; Provenzale, J.M.; Gururangan, S.; Tourt-Uhlig, S.; Herndon, J.E.; Bigner, D.D.; Friedman, H.S., 2002:
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma

Wierzbicki, R.; Ezzat, A.; Abdel-Warith, A.; Ayoub, A.; Kagevi, I.; Fadda, M.; Sieck, J.; Abdulkareem, M.; Amin, T.; Yazigi, A., 1994:
Phase II trial of chronic daily VP-16 administration in unresectable hepatocellular carcinoma (HCC)

Cure, H.; Chevalier, V.; Pezet, D.; Bousquet, J.; Focan, C.; Levi, F.; Garufi, C.; Chipponi, J.; Chollet, P., 2001:
Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer

Curé, H.; Chevalier, V.; Adenis, A.; Tubiana-Mathieu, N.; Niezgodzki, G.; Kwiatkowski, F.; Pezet, D.; Perpoint, B.; Coudert, B.; Focan, C.; Lévi, F.; Chipponi, J.; Chollet, P., 2002:
Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer

Hitt, R.; Castellano, D.; Hidalgo, M.; García-Carbonero, R.; Peña, M.; Brandariz, A.; Millán, J.M.; Alvarez Vincent, J.J.; Cortés-Funes, H., 1999:
Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck

Patt, Y.Z.; Hassan, M.M.; Lozano, R.D.; Waugh, K.A.; Hoque, A.M.; Frome, A.I.; Lahoti, S.; Ellis, L.; Vauthey, J.N.; Curley, S.A.; Schnirer, I.I.; Raijman, I., 2001:
Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer

Viñolas, N.; Graus, F.; Mellado, B.; Caralt, L.; Estapé, J., 1997:
Phase II trial of cisplatinum and etoposide in brain metastases of solid tumors

Nakanishi, Y.; Kawarada, Y.; Hirose, N.; Ninomiya, K.; Miyazaki, M.; Miyazaki, N.; Kurita, Y.; Kanegae, H.; Ohgushi, O.; Ogata, K.; Yamazaki, H.; Inutsuka, S.; Hara, N., 1998:
Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer. Fukuoka Lung Cancer Study Group

Eckel, F.; Lersch, C.; Lippl, F.; Assmann, G.; Schulte-Frohlinde, E., 2001:
Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer

Roche, H.; Cure, H.; Adenis, A.; Fargeot, P.; Terret, C.; Lentz, M.A.; Madelmont, J.C.; Fumoleau, P.; Hanausk, A.; Chollet, P., 2001:
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults

Ramanathan, R.K.; Cnaan, A.; Hahn, R.G.; Carbone, P.P.; Haller, D.G., 2001:
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282

Hendren, S.K.; Hahn, S.M.; Spitz, F.R.; Bauer, T.W.; Rubin, S.C.; Zhu, T.; Glatstein, E.; Fraker, D.L., 2001:
Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors

Pazdur, R.; Lassere, Y.; Soh, L.T.; Ajani, J.A.; Bready, B.; Soo, E.; Sugarman, S.; Patt, Y.; Abbruzzese, J.L.; Levin, B., 1994:
Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma

Francis, P.A.; Rigas, J.R.; Kris, M.G.; Pisters, K.M.; Orazem, J.P.; Woolley, K.J.; Heelan, R.T., 1994:
Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

Smith, R.E.; Anderson, S.J.; Brown, A.; Scholnik, A.P.; Desai, A.M.; Kardinal, C.G.; Lembersky, B.C.; Mamounas, E.P., 2003:
Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58

Buesa, J.M.; López-Pousa, A.; Martín, J.; Antón, A.; García del Muro, J.; Bellmunt, J.; Arranz, F.; Valentí, V.; Escudero, P.; Menéndez, D.; Casado, A.; Poveda, A., 1998:
Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)

Foss, F.M.; Ihde, D.C.; Linnoila, I.R.; Fischmann, A.B.; Schechter, G.P.; Cotelingam, J.D.; Steinberg, S.M.; Ghosh, B.C.; Stocker, J.L.; Bastian, A., 1994:
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome

Feliu, J.; López Alvarez, M.P.; Jaraiz, M.A.; Constenla, M.; Vicent, J.M.; Belón, J.; López Gómez, L.; de Castro, J.; Dorta, J.; González Barón, M., 2000:
Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group

Sandler, A.B.; Kindler, H.L.; Einhorn, L.H.; Mitchell, E.; Masters, G.; Kraut, M.; Nicol, S.; Raghavan, D., 2000:
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction

O'Shaughnessy, J.; Vukelja, S.J.; Marsland, T.; Kimmel, G.; Ratnam, S.; Pippen, J., 2002:
Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary results

Sánchez-Rovira, P.; Jaén, A.; González, E.; Porras, I.; Dueñas, M.R.; Medina, B.; Mohedano, N.; Fernández, M.; Martos, M.; Lozano, A., 2002:
Phase II trial of gemcitabine/doxorubicin/paclitaxel administered every other week in patients with metastatic breast cancer

Nieto, Y.; Cagnoni, P.J.; Shpall, E.J.; Matthes, S.; Barón, A.; Jones, R.B.; Bearman, S.I., 1999:
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease

Shapiro, C.L.; Ervin, T.; Welles, L.; Azarnia, N.; Keating, J.; Hayes, D.F., 1999:
Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group

Goedhals, L.; Vorobiof, D.A.; Bezwoda, W.; Van Merwe, A.; Jordaan, J.P.; Barnardt, P.; Smith, B.L., 2000:
Phase II trial of i.v. vinorelbine and cisplatin in inoperable locally advanced or disseminated non-small-cell lung cancer: the South African experience

Schilder, R.J.; Goldberg, M.; Millenson, M.M.; Movsas, B.; Rogatko, A.; Rogers, B.; Langer, C.J., 2000:
Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung

Janik, J.E.; Miller, L.L.; Longo, D.L.; Powers, G.C.; Urba, W.J.; Kopp, W.C.; Gause, B.L.; Curti, B.D.; Fenton, R.G.; Oppenheim, J.J.; Conlon, K.C.; Holmlund, J.T.; Sznol, M.; Sharfman, W.H.; Steis, R.G.; Creekmore, S.P.; Alvord, W.G.; Beauchamp, A.E.; Smith, J.W., 1996:
Phase II trial of interleukin 1 alpha and indomethacin in treatment of metastatic melanoma

Dutcher, J.P.; Logan, T.; Gordon, M.; Sosman, J.; Weiss, G.; Margolin, K.; Plasse, T.; Mier, J.; Lotze, M.; Clark, J.; Atkins, M., 2000:
Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study

Guastalla, J.P.; Lhomme, C.; Kerbrat, P.; Mayer, F.; Namer, M.; Goupil, P.; Charrot, P.; Heron, J.F.; Chazard, M.; Richard, I., 1994:
Phase II trial of intraperitoneal carboplatin in ovarian carcinoma patients with macroscopic residual disease at second-look laparotomy. A multicentre study of the French Fédération Nationale des Centres de Lutte Contre le Cancer

Morgan, R.J.; Braly, P.; Cecchi, G.; Leong, L.; Shibata, S.; Margolin, K.; Somlo, G.; McNamara, M.; Longmate, J.; Schinke, S.; Raschko, J.; Nagasawa, S.; Kogut, N.; Parker, P.; Stein, A.; Cho, J.; Smith, E.; Coluzzi, P.; Najera, L.; Johnson, D.; Womack, E.; Doroshow, J.H., 1999:
Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up

Patt, Y.Z.; Jones, D.V.; Hoque, A.; Lozano, R.; Markowitz, A.; Raijman, I.; Lynch, P.; Charnsangavej, C., 1996:
Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer

Bodurka, D.C.; Levenback, C.; Wolf, J.K.; Gano, J.; Wharton, J.Taylor.; Kavanagh, J.J.; Gershenson, D.M., 2003:
Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer

Murad, A.M..; Oliveira, M..; Saldanha, T.M.., 1994:
Phase II trial of isotretinoin and interferon alpha-2a in the treatment of advanced recurrent cervical carcinoma

Steele, J.P.; O'Doherty, C.A.; Shamash, J.; Evans, M.T.; Gower, N.H.; Tischkowitz, M.D.; Rudd, R.M., 2001:
Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma

Chidiac, T.; Budd, G.T.; Pelley, R.; Sandstrom, K.; McLain, D.; Elson, P.; Crownover, R.; Marks, K.; Muschler, G.; Joyce, M.; Zehr, R.; Bukowski, R., 2000:
Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas

Eckel, F.; Lersch, C.; Assmann, G.; Schulte-Frohlinde, E., 2000:
Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer

Malik, U.R.; Dutcher, J.P.; Caliendo, G.; Lasala, P.; Mitnick, R.; Wiernik, P.H., 1998:
Phase II trial of merbarone in patients with malignant brain tumors

Taal, B.G.; Audisio, R.A.; Bleiberg, H.; Blijham, G.H.; Neijt, J.P.; Veenhof, C.H.; Duez, N.; Sahmoud, T., 1993:
Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study

Reardon, D.A.; Akabani, G.; Coleman, R.Edward.; Friedman, A.H.; Friedman, H.S.; Herndon, J.E.; Cokgor, I.; McLendon, R.E.; Pegram, C.N.; Provenzale, J.M.; Quinn, J.A.; Rich, J.N.; Regalado, L.V.; Sampson, J.H.; Shafman, T.D.; Wikstrand, C.J.; Wong, T.Z.; Zhao, X-Guang.; Zalutsky, M.R.; Bigner, D.D., 2002:
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas

Alonso, V.; Santader, C.; Florian, J.; Alonso, M.; Isla, M.D.; Escudero, P.; Saenz, A.; Tres, A., 1996:
Phase II trial of oral tegafur and folinic acid with mitoxantrone as first-line regimen in patients with metastatic breast cancer

Degardin, M.; Cappelaere, P.; Krakowski, I.; Fargeot, P.; Cupissol, D.; Brienza, S., 1996:
Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck

Bécouarn, Y.; Ychou, M.; Ducreux, M.; Borel, C.; Bertheault-Cvitkovic, F.; Seitz, J.F.; Nasca, S.; Nguyen, T.D.; Paillot, B.; Raoul, J.L.; Duffour, J.; Fandi, A.; Dupont-André, G.; Rougier, P., 1998:
Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers

Thomas, P.; Castelnau, O.; Paillotin, D.; Léna, H.; Robinet, G.; Muir, J.F.; Delaval, P.; Gouva, S.; Balmes, P.; Blanchon, F.; Perdu, D.; Poirier, R.; Pommier, D.S.nti, P.; Penot-Ragon, C.; Kleisbauer, J.P., 2001:
Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study

Breathnach, O.S.; Georgiadis, M.S.; Schuler, B.S.; Pizzella, P.; Llorens, V.; Kasturi, V.; Steinberg, S.M.; O'Neil, K.; Takimoto, C.H.; Johnson, B.E., 2000:
Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer

Yamada, Y.; Shirao, K.; Ohtsu, A.; Boku, N.; Hyodo, I.; Saitoh, H.; Miyata, Y.; Taguchi, T., 2001:
Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions

Ratanatharathorn, V.; Lorvidhaya, V.; Maoleekoonpairoj, S.; Phromratanapongse, P.; Sirilerttrakul, S.; Kraipiboon, P.; Cheirsilpa, A.; Tangkaratt, S.; Srimuninnimit, V.; Pattaranutaporn, P., 2001:
Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

Skubitz, K.M., 2002:
Phase II trial of pegylated-liposomal doxorubicin (Doxil) in mesothelioma

Skubitz, K.M., 2002:
Phase II trial of pegylated-liposomal doxorubicin (Doxil) in renal cell cancer

Clarke, S.J.; Abratt, R.; Goedhals, L.; Boyer, M.J.; Millward, M.J.; Ackland, S.P., 2002:
Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer

Taylor, S.A.; Benedetti, J.; Schuller, D.; Richman, S.P.; Broun, G.O.; Hantel, A., 1993:
Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trial

Kuratsu, J.I.; Arita, N.; Kayama, T.; Kubo, N.; Mori, T.; Sawamura, Y.; Ushio, Y., 2000:
Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients

Mehta, V.K.; Cho, C.; Ford, J.M.; Jambalos, C.; Poen, J.; Koong, A.; Lin, A.; Bastidas, J.Augusto.; Young, H.; Dunphy, E.P.; Fisher, G., 2002:
Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer

Buckner, J.C.; Gesme, D.; O'Fallon, J.R.; Hammack, J.E.; Stafford, S.; Brown, P.D.; Hawkins, R.; Scheithauer, B.W.; Erickson, B.J.; Levitt, R.; Shaw, E.G.; Jenkins, R., 2003:
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities

Berg, S.L.; Blaney, S.M.; Sullivan, J.; Bernstein, M.; Dubowy, R.; Harris, M.B., 2000:
Phase II trial of pyrazoloacridine in children with solid tumors: a Pediatric Oncology Group phase II study

Bramhall, S.R.; Harrison, J.D.; Burton, A.; Wallace, D.M.; Chan, K.K.; Harrison, G.; White, A.; Fielding, J.W., 1999:
Phase II trial of radical surgery for locally advanced pelvic neoplasia

Buckner, J.C.; Burch, P.A.; Cascino, T.L.; O'Fallon, J.R.; Scheithauer, B.W., 1998:
Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma

Palmero, D.; Eiguchi, K.; Rendo, P.; Castro Zorrilla, L.; Abbate, E.; González Montaner, L.J., 1999:
Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up

Redman, B.G.; Hillman, G.G.; Flaherty, L.; Forman, J.; Dezso, B.; Haas, G.P., 1998:
Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinoma

Dillman, R.O.; Soori, G.; Wiemann, M.C.; Schulof, R.; Dobbs, T.W.; Ruben, R.H.; DePriest, C.B.; Church, C., 2001:
Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: final results of cancer biotherapy research group 94-11

Patt, Y.Z.; Hassan, M.M.; Lozano, R.D.; Brown, T.D.; Vauthey, J.Nicolas.; Curley, S.A.; Ellis, L.M., 2003:
Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

Groves, M.D.; Puduvalli, V.K.; Hess, K.R.; Jaeckle, K.A.; Peterson, P.; Yung, W.K.Alfred.; Levin, V.A., 2002:
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme

Motzer, R.J.; Berg, W.; Ginsberg, M.; Russo, P.; Vuky, J.; Yu, R.; Bacik, J.; Mazumdar, M., 2002:
Phase II trial of thalidomide for patients with advanced renal cell carcinoma

Escudier, B.; Lassau, N.; Couanet, D.; Angevin, E.; Mesrati, F.; Leborgne, S.; Garofano, A.; Leboulaire, C.; Dupouy, N.; Laplanche, A., 2002:
Phase II trial of thalidomide in renal-cell carcinoma

Judson, I.; Cerny, T.; Epelbaum, R.; Dunlop, D.; Smyth, J.; Schaefer, B.; Roelvink, M.; Kaplan, S.; Hanauske, A., 1997:
Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigation

Muggia, F.M.; Blessing, J.A.; Sorosky, J.; Reid, G.C., 2002:
Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study

Bedikian, A.Y.; Legha, S.S.; Eton, O.; Buzaid, A.C.; Papadopoulos, N.; Coates, S.; Simmons, T.; Neefe, J.; von Roemeling, R., 1997:
Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma

Blaney, S.M.; Needle, M.N.; Gillespie, A.; Sato, J.K.; Reaman, G.H.; Berg, S.L.; Adamson, P.C.; Krailo, M.D.; Bleyer, W.A.; Poplack, D.G.; Balis, F.M., 1998:
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study

Penz, M.; Kornek, G.V.; Raderer, M.; Ulrich-Pur, H.; Fiebiger, W.; Lenauer, A.; Depisch, D.; Krauss, G.; Schneeweiss, B.; Scheithauer, W., 2001:
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

Hügli, A.; Moro, D.; Mermillod, B.; Bolla, M.; Alberto, P.; Bonnefoi, H.; Miralbell, R., 2000:
Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines

Mani, S.; Kugler, J.W.; Sciortino, D.F.; Garcia, J.C.; Ansari, R.H.; Humerickhouse, R.; Michelassi, F.; Posner, M.C.; Shulman, K.L.; Schilsky, R.L.; List, M.; Vokes, E.E.; Benner, S., 1998:
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study

Conroy, T.; Etienne, P.L.; Adenis, A.; Wagener, D.J.; Paillot, B.; François, E.; Bedenne, L.; Jacob, J.H.; Seitz, J.F.; Bleiberg, H.; Van Pottelsberghe, C.; Van Glabbeke, M.; Delgado, F.M.; Merle, S.; Wils, J., 1996:
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group

Choy, H.; Safran, H.; Akerley, W.; Graziano, S.L.; Bogart, J.A.; Cole, B.F., 1998:
Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer

Vaughn, D.J.; Broome, C.M.; Hussain, M.; Gutheil, J.C.; Markowitz, A.B., 2002:
Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancer

Markman, M.; Hall, J.; Spitz, D.; Weiner, S.; Carson, L.; Van Le, L.; Baker, M., 2002:
Phase II trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer

Jahanzeb, M.; Mortimer, J.E.; Yunus, F.; Irwin, D.H.; Speyer, J.; Koletsky, A.J.; Klein, P.; Sabir, T.; Kronish, L., 2002:
Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer

Knox, S.J.; Goris, M.L.; Tempero, M.; Weiden, P.L.; Gentner, L.; Breitz, H.; Adams, G.P.; Axworthy, D.; Gaffigan, S.; Bryan, K.; Fisher, D.R.; Colcher, D.; Horak, I.D.; Weiner, L.M., 2000:
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer

Markman, M.; DeMarco, L.C.; Birkhofer, M.; Budman, D.; Hakes, T.; Reichman, B.; Rubin, S.; Jones, W.; Barakat, R.; Curtin, J., 1993:
Phase II trial of zeniplatin (CL 286,558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy

Rebattu, P.; Coudert, B.; Schneider, M.; Ouabdesselam, R.; Lentz, M.; Hanauske, A.; Chevallierdagger, B.; Fumoleau, P.; Chollet, P., 2000:
Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma

Wils, J.A.; Kok, T.; Wagener, D.J.; Francois, E.; Selleslags, J.; Duez, N., 1993:
Phase II trial with ifosfamide in pancreatic cancer

Richardet, E.; Carranza, L.; Uribe, A.; Tolocka, H.; Cresta, C.; Uribe, E.; Uribe, M., 1995:
Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma

Sardi, J.E., 1996:
Phase II trial with neoadjuvant chemotherapy

Shelley, J.H., 1999:
Phase II trials in drug development

Kraut, E.H., 2000:
Phase II trials of pentostatin (Nipent) in hairy cell leukemia

Smith, M.A.; Anderson, B., 2001:
Phase II window studies: 10 years of experience and counting

Pantely, G.A.; Joyce, M.; Grauer, S.E.; Giraud, G.D.; Shiota, T.; Sahn, D., 1998:
Phase II, placebo-controlled trial of MRX115 (Aerosomes) for left heart and myocardial perfusion imaging

Kabbinavar, F.; Hurwitz, H.I.; Fehrenbacher, L.; Meropol, N.J.; Novotny, W.F.; Lieberman, G.; Griffing, S.; Bergsland, E., 2002:
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

Krown, S.E.; Aeppli, D.; Balfour, H.H., 1999:
Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team

Coughlin, C.; Scott, C.; Langer, C.; Coia, L.; Curran, W.; Rubin, P., 2000:
Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients

Goorin, A.M.; Harris, M.B.; Bernstein, M.; Ferguson, W.; Devidas, M.; Siegal, G.P.; Gebhardt, M.C.; Schwartz, C.L.; Link, M.; Grier, H.E., 2002:
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial

Werner-Wasik, M.; Axelrod, R.S.; Friedland, D.P.; Hauck, W.; Rose, L.J.; Chapman, A.E.; Grubbs, S.; Deshields, M.; Curran, W.J., 2002:
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy

Anonymous, 1999:
Phase III CCRE option

Xu, B.; Zhou, J.; Zhou, A., 2000:
Phase III clinical studies with ondansetron (Qilu) in the prophylaxis of nausea and vomiting induced by cisplatin

Zhou, J.; Xu, B.; Zhou, A., 2000:
Phase III clinical studies with ondansetron (Qilu) in the prophylaxis of nausea and vomiting induced by non-cisplatin chemotherapy

Li, Q.; Feng, F-yi.; Han, J.; Sui, G-jie.; Zhu, Y-guang.; Zhang, Y.; Zhang, Z-hua.; Li, L.; Wang, P-hui.; Zhou, M-zhen.; Zhang, Y-chao., 2003:
Phase III clinical study of a new anticancer drug atofluding

Poirier, V.C.; Newberry, P.D.; Hecht, S.T.; Nemzek, W.R., 1996:
Phase III clinical trial comparing iodixanol and iohexol in cerebral angiography

Kimura, S.; Shimada, K.; Matsuda, J.; Gohchi, K.; Fukutake, K.; Fukue, H.; Okubo, T.; Ishigatsubo, Y.; Yamada, K.; Koitabashi, Y., 1994:
Phase III clinical trial of KRN8601 (rhG-CSF) for neutropenia in patients with human immunodeficiency virus infection

Luetje, C.M.; Brackman, D.; Balkany, T.J.; Maw, J.; Baker, R.Stanley.; Kelsall, D.; Backous, D.; Miyamoto, R.; Parisier, S.; Arts, A., 2002:
Phase III clinical trial results with the Vibrant Soundbridge implantable middle ear hearing device: a prospective controlled multicenter study

Morere, J.F., 2002:
Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001

Zinzani, P.L.; Martelli, M.; Storti, S.; Musso, M.; Cantonetti, M.; Leone, G.; Cajozzo, A.; Papa, G.; Iannitto, E.; Perrotti, A., 1995:
Phase III comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-Hodgkin's lymphoma

Mochiki, H.; Yamamoto, O.; Mizumoto, A.; Ito, S., 1995:
Phase III contraction inhibition and gastric acidification in Pavlov and Heidenhain pouch in dogs

Muggia, F.; Hamilton, A., 2001:
Phase III data on Caelyx in ovarian cancer

Zimniak, P.; Awasthi, S.; Awasthi, Y.C., 1993:
Phase III detoxification system

Vore, M., 1994:
Phase III elimination: another two-edge sword

Loprinzi, C.L.; Sloan, J.A.; Perez, E.A.; Quella, S.K.; Stella, P.J.; Mailliard, J.A.; Halyard, M.Y.; Pruthi, S.; Novotny, P.J.; Rummans, T.A., 2002:
Phase III evaluation of fluoxetine for treatment of hot flashes

Burch, P.A.; Block, M.; Schroeder, G.; Kugler, J.W.; Sargent, D.J.; Braich, T.A.; Mailliard, J.A.; Michalak, J.C.; Hatfield, A.K.; Wright, K.; Kuross, S.A., 2000:
Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study

Anonymous, 2001:
Phase III hepatitis C program begins

Fort, D.J.; Stover, E.L.; Bantle, J.A.; Rayburn, J.R.; Hull, M.A.; Finch, R.A.; Burton, D.T.; Turley, S.D.; Dawson, D.A.; Linder, G.; Buchwalter, D.; Dumont, J.N.; Kumsher-King, M.; Gaudet-Hull, A.M., 1998:
Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX)

Grayburn, P.A.; Weiss, J.L.; Hack, T.C.; Klodas, E.; Raichlen, J.S.; Vannan, M.A.; Klein, A.L.; Kitzman, D.W.; Chrysant, S.G.; Cohen, J.L.; Abrahamson, D.; Foster, E.; Perez, J.E.; Aurigemma, G.P.; Panza, J.A.; Picard, M.H.; Byrd, B.F.; Segar, D.S.; Jacobson, S.A.; Sahn, D.J.; DeMaria, A.N., 1998:
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms

Feurle, G.E.; Pfeiffer, A.; Schmidt, T.; Dominguez-Munoz, E.; Malfertheiner, P.; Hamscher, G., 2001:
Phase III of the migrating motor complex: associated with endogenous xenin plasma peaks and induced by exogenous xenin

Rosell, R.; Gatzemeier, U.; Betticher, D.C.; Keppler, U.; Macha, H.N.; Pirker, R.; Berthet, P.; Breau, J.L.; Lianes, P.; Nicholson, M.; Ardizzoni, A.; Chemaissani, A.; Bogaerts, J.; Gallant, G., 2002:
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

André, M.; Baudoux, E.; Bron, D.; Canon, J-Luc.; D'Hondt, Véronique.; Fassotte, M-France.; D'Hondt, L.; Fillet, G.; Humblet, Y.; Jerusalem, G.; Vermeulen, P.; Symann, M.; Beguin, Y., 2003:
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies

Levin, V.A.; Uhm, J.H.; Jaeckle, K.A.; Choucair, A.; Flynn, P.J.; Yung WKA; Prados, M.D.; Bruner, J.M.; Chang, S.M.; Kyritsis, A.P.; Gleason, M.J.; Hess, K.R., 2000:
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme

Sculier, J.P.; Paesmans, M.; Thiriaux, J.; Lecomte, J.; Bureau, G.; Giner, V.; Efremidis, A.; Lafitte, J.J.; Berchier, M.C.; Alexopoulos, C.G.; Zacharias, C.; Mommen, P.; Ninane, V.; Klastersky, J., 1998:
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party

Scagliotti, G.V.; De Marinis, F.; Rinaldi, M.; Crinò, L.; Gridelli, C.; Ricci, S.; Matano, E.; Boni, C.; Marangolo, M.; Failla, G.; Altavilla, G.; Adamo, V.; Ceribelli, A.; Clerici, M.; Di Costanzo, F.; Frontini, L.; Tonato, M., 2002:
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer

Vikram, B., 2001:
Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

Pass, H.I.; Temeck, B.K.; Kranda, K.; Thomas, G.; Russo, A.; Smith, P.; Friauf, W.; Steinberg, S.M., 1998:
Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma

Anonymous, 1998:
Phase III results of second-generation HIV protease inhibitor reported

Anonymous, 2001:
Phase III results presented on amprenavir triple combination

Anonymous, 1995:
Phase III saquinavir clinical trials

Johnstone, D.W.; Byhardt, R.W.; Ettinger, D.; Scott, C.B., 2002:
Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group

Takada, M.; Fukuoka, M.; Kawahara, M.; Sugiura, T.; Yokoyama, A.; Yokota, S.; Nishiwaki, Y.; Watanabe, K.; Noda, K.; Tamura, T.; Fukuda, H.; Saijo, N., 2002:
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104

Renard, A.; Noël, G.; Mazeron, J.J., 2000:
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesin and cisplatin in unresectable stage III non small-cell lung cancer

Berlin, J.D.; Catalano, P.; Thomas, J.P.; Kugler, J.W.; Haller, D.G.; Benson, A.Bowen., 2002:
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297

Shimizu, Y., 2002:
Phase III study of gynecologic cancer in Japan

Furuse, K.; Fukuoka, M.; Nishiwaki, Y.; Kurita, Y.; Watanabe, K.; Noda, K.; Ariyoshi, Y.; Tamura, T.; Saijo, N., 1998:
Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group

Emami, B.; Scott, C.; Perez, C.A.; Asbell, S.; Swift, P.; Grigsby, P.; Montesano, A.; Rubin, P.; Curran, W.; Delrowe, J.; Arastu, H.; Fu, K.; Moros, E., 1996:
Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group

Socinski, M.A.; Schell, M.J.; Peterman, A.; Bakri, K.; Yates, S.; Gitten, R.; Unger, P.; Lee, J.; Lee, J-Hyun.; Tynan, M.; Moore, M.; Kies, M.S., 2002:
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer

Nabholtz, J-Marc.; Cantin, J.; Chang, J.; Guevin, R.; Patel, R.; Tkaczuk, K.; Vodvarka, P.; Lindsay, M-Ann.; Reese, D.; Riva, A.; Mackey, J., 2002:
Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial

Pearcey, R.; Brundage, M.; Drouin, P.; Jeffrey, J.; Johnston, D.; Lukka, H.; MacLean, G.; Souhami, L.; Stuart, G.; Tu, D., 2002:
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix

Anonymous, 2000:
Phase III trial of IL-2

Gibson, A.D., 2002:
Phase III trial of a humanized anti-CD33 antibody (HuM195) in patients with relapsed or refractory acute myeloid leukemia

Matveeva, A.G.; Nekrasov, V.M.; Maryasov, A.G., 2017:
Analytical solution of the PELDOR inverse problem using the integral Mellin transform

Falkson, C.I.; Ibrahim, J.; Kirkwood, J.M.; Coates, A.S.; Atkins, M.B.; Blum, R.H., 1998:
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study

Siefker-Radtke, A.O.; Millikan, R.E.; Tu, S-Ming.; Moore, D.F.; Smith, T.L.; Williams, D.; Logothetis, C.J., 2002:
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer

Schrijvers, D.; Johnson, J.; Jiminez, U.; Gore, M.; Kosmidis, P.; Szpirglas, H.; Robbins, K.; Oliveira, J.; Lewensohn, R.; Schüller, J.; Riviere, A.; Arvay, C.; Langecker, P.; Jacob, H.; Cvitkovic, E.; Vokes, E., 1998:
Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group

Anonymous, 1999:
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of radiation therapy oncology group 89-03

MacVicar, D.; Jacobsen, T.F.; Guy, R.; Husband, J.E., 1993:
Phase III trial of oral magnetic particles in MRI of abdomen and pelvis

Anonymous, 2001:
Phase III trials for new PI

Richieri, S., 1995:
Phase III trials for whole inactivated HIV

Gams, R., 1997:
Phase III trials of toremifene vs tamoxifen

Bodsworth, N.J.; Bloch, M.; Bower, M.; Donnell, D.; Yocum, R., 2001:
Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma

Dunn, B.K.; Kramer, B.S.; Ford, L.G., 1999:
Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experience

Greco, A.; Parker, J.R.; Ratcliffe, C.G.; Kirchin, M.A.; McNamara, M.T., 2002:
Phase III, randomized, double-blind, cross-over comparison of gadoteridol and gadopentetate dimeglumine in magnetic resonance imaging of patients with intracranial lesions

Arimori, S.; Terada, H.; Hayami, K.; Aoyagi, Y.; Motomura, S.; Fukawa, H.; Akatsuka, N.; Shimizu, S.; Kodama, F.; Chiba, S., 1993:
Phase IV group study of natural human interferon alpha (HLBI) on chronic myelogeneous leukaemia

Segura, A.; Villalbí, J.R., 1996:
Phase IV of epidemiological studies: conceptual and methodological criticisms

Li, J.T.; Yoshida, M.; Nakatsuka, K., 1995:
Phase IV study (postmarketing surveillance) of Tarivid (ofloxacin) in China

Anonymous, 1996:
Phase Ia trial of a polynucleotide anti-tumor immunization to human carcinoembryonic antigen in patients with metastatic colorectal cancer. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama

Brooks, D.; Taylor, C.; Dos Santos, B.; Linden, H.; Houghton, A.; Hecht, T.T.; Kornfeld, S.; Taetle, R., 1995:
Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6

Grant, S.; Roberts, J.; Poplin, E.; Tombes, M.B.; Kyle, B.; Welch, D.; Carr, M.; Bear, H.D., 1998:
Phase Ib trial of bryostatin 1 in patients with refractory malignancies

Cui; Zhang; Chen, 2000:
Phase Lag and Coherence Function of X-Ray Emission from Black Hole Candidate XTE J1550-564

Friedrich; Trost, 1996 :
Phase Loss in WKB Waves Due to Reflection by a Potential

Lacasta; Sancho; Sagués, 1995:
Phase Separation Dynamics under Stirring

Müller-Buschbaum; O'Neill; Affrossman; Stamm, 1998:
Phase Separation and Dewetting of Weakly Incompatible Polymer Blend Films

Cho; Chou; Johnston, 1993:
Phase Separation and Finite Size Scaling in La2-xSrxCuO4+ delta

Kumar; Weinhold, 1996:
Phase Separation in Nearly Symmetric Polymer Mixtures

van Dongen PG, 1995:
Phase Separation in the Extended Hubbard Model at Weak Coupling

Tuinier; de Kruif CG, 1999:
Phase Separation, Creaming, and Network Formation of Oil-in-Water Emulsions Induced by an Exocellular Polysaccharide

Sheng; Chen; Weng, 1996:
Phase String Effect in a Doped Antiferromagnet

So; Park; Kim; Moon, 1997:
Phase Transformation Behavior at Low Temperature in Hydrothermal Treatment of Stable and Unstable Titania Sol

Fainerman; Miller, 2000:
Phase Transition Processes in Surfactant Adsorption Layers

Ueda; Yoshikawa, 1996:
Phase Transition and Phase Segregation in a Single Double-Stranded DNA Molecule

Robinson; Drysdale, 1996:
Phase Transition between Coherent and Incoherent Three-Wave Interactions

Collins; Dhathathreyan; Ramasami, 1998:
Phase Transition in Langmuir Films of Octadecylmalonic Acid

Hill; Zia; Schmittmann, 1996:
Phase Transitions in Driven Bilayer Systems: A Monte Carlo Study

Heiselberg; Hjorth-Jensen, 1999:
Phase Transitions in Neutron Stars and Maximum Masses

Martín-Delgado; Shankar; Sierra, 1996:
Phase Transitions in Staggered Spin Ladders

Martin, S.T.., 2002:
Phase Transitions of Aqueous Atmospheric Particles

Cao, P.; Luo, J.; Zhu, T., 2003:
Phase aberration correction for ultrasound imaging

Ries, L.L.; Smith, S.W., 1995:
Phase aberration correction in two dimensions using a deformable array transducer

Debbins, J.P.; Felmlee, J.P.; Riederer, S.J., 1997:
Phase alignment of multiple surface coil data for reduced bandwidth and reconstruction requirements

Van Isacker P; Frank; Dukelsky, 1985:
Phase ambiguities in the O(6) limit of the interacting boson model

Turnipseed, D.L., 2000 :
Phase analysis of burnout and other psychological phenomena

Smith, 1985:
Phase analysis of image states and surface states associated with nearly-free-electron band gaps

Ginter, J.; Blinowska, K.J.; Kamiński, M.; Durka, P.J., 2001:
Phase and amplitude analysis in time-frequency space--application to voluntary finger movement

Ciuchi; San Miguel M; Abraham; de Pasquale F, 1991:
Phase and amplitude correlations induced by the switch-on chirp of a detuned laser

Zeghlache; Mandel; Abraham; Weiss, 1988:
Phase and amplitude dynamics in the laser Lorenz model

Bestehorn, 1993:
Phase and amplitude instabilities for Bénard-Marangoni convection in fluid layers with large aspect ratio

Wu; Griffin, 1995:
Phase and amplitude modes in a superconductor with interlayer pair tunneling

Launois; Moussa; Lemée-Cailleau; Cailleau, 1989:
Phase and amplitude modes of the n=4 incommensurate phase II of biphenyl: Neutron scattering experiments and theoretical results

Nicolás, J.; Campos, J.; Yzuel, Mía.J., 2002:
Phase and amplitude modulation of elliptic polarization states by nonabsorbing anisotropic elements: application to liquid-crystal devices

Widmann; Sugai; Yamazaki; Hayano; Iwasaki; Nakamura; Tamura; Ito; Kawachi; Nishida; Higemoto; Ito; Morita; Hartmann; Daniel; von Egidy T; Schmid; Hoffmann; Eades, 1995:
Phase and density dependence of the delayed annihilation of metastable antiprotonic helium atoms in gas, liquid, and solid helium

Kesar, A.; Jerby, E., 2002:
Phase and gain measurements in a distributed-loss cyclotron-resonance maser amplifier

Padilla, F.; Laugier, P., 2000:
Phase and group velocities of fast and slow compressional waves in trabecular bone

Braunstein; Caves, 1990:
Phase and homodyne statistics of generalized squeezed states

Blank; Shapiro, 1995:
Phase and intensity control of integral and differential above-threshold ionization rates

Huang, 1994:
Phase and photon-number squeezings in a many-cascade two-photon correlated-spontaneous-emission laser

Conti, M., 2002:
Phase and solute fields across the solid-liquid interface of a binary alloy

Meng; Chai; Zhang, 1993:
Phase and squeezing properties of two copropagating fields in a Kerr medium

Dzakula, 2000:
Phase angle measurement from peak areas (PAMPAS)

Chumlea, W.C.; Guo, S.S.; Siervogel, R.M., 1998:
Phase angle spectrum analysis and body water

Ning; Haken, 1991:
Phase anholonomy in dissipative optical systems with periodic oscillations

Littlejohn, 1988 :
Phase anholonomy in the classical adiabatic motion of charged particles

Brasunas, J.C., 2002:
Phase anomalies in fourier-transform spectrometers: an absorbing beam splitter is neither sufficient nor necessary

Fried; Gabellini, 1995:
Phase averaging and generalized eikonal representations

Jamee; Pitsi; Li; Nguyen; Sigaud; Thoen, 2000:
Phase behavior and blue-phase-III-isotropic critical point in (R)-(S) mixtures of a chiral liquid crystal with a direct twist-grain-boundary to blue-phase transition

Bates, M.A., 2002:
Phase behavior and free interfaces of a lattice-gas nematic-liquid-crystal model

Schwarz; Safran, 2000:
Phase behavior and material properties of hollow nanoparticles

Wilding, N.B.; Magee, J.E., 2002:
Phase behavior and thermodynamic anomalies of core-softened fluids

Knoll, A.; Horvat, A.; Lyakhova, K.S.; Krausch, G.; Sevink, G.J.A.; Zvelindovsky, A.V.; Magerle, R., 2002:
Phase behavior in thin films of cylinder-forming block copolymers

van Der Kooij FM; Vogel; Lekkerkerker, 2000:
Phase behavior of a mixture of platelike colloids and nonadsorbing polymer

Ilett; Orrock; Poon; Pusey, 1995:
Phase behavior of a model colloid-polymer mixture

Sear, 2000 :
Phase behavior of a model of colloidal particles with a fluctuating internal state

Klapp, S.; Forstmann, F., 2002:
Phase behavior of aligned dipolar hard spheres: integral equations and density functional results

Lu, Q.; Zografi, G., 1998:
Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid, and PVP

Velasco, E.; Navascués, G.; Mederos, L., 2002:
Phase behavior of binary hard-sphere mixtures from perturbation theory

Brunner, M.; Bechinger, C., 2002:
Phase behavior of colloidal molecular crystals on triangular light lattices

Harreis, H.M.; Kornyshev, A.A.; Likos, C.N.; Löwen, H.; Sutmann, G., 2002:
Phase behavior of columnar DNA assemblies

Di Biasio A; Cametti; Codastefano; Tartaglia; Rouch; Chen, 1993:
Phase behavior of dense three-component ionic microemulsions and electrical conductivity in the lamellar phase

Veerman; Frenkel, 1992:
Phase behavior of disklike hard-core mesogens

Dijkstra, M., 2002:
Phase behavior of hard spheres with a short-range Yukawa attraction

Bates; Frenkel, 2000:
Phase behavior of model mixtures of colloidal disks and polymers

Zhang; Laradji; Guo; Mouritsen; Zuckermann, 1992:
Phase behavior of pure lipid bilayers with mismatch interactions

Rosenbaum; Zamora; Zukoski, 1996:
Phase behavior of small attractive colloidal particles

Huang; Gibbs; Zehner; Sandy; Mochrie, 1990:
Phase behavior of the Au(111) surface: Discommensurations and kinks

Al-Bawab, A.; Friberg, S.E., 2002:
Phase behavior of the alpha-hydroxyoctanoic acid/Laureth 4/white oil/water system and preliminary evaluation of the phase changes during evaporation of its emulsion

Bellini; Clark; Muzny; Wu; Garland; Schaefer; Oliver, 1992:
Phase behavior of the liquid crystal 8CB in a silica aerogel

Qiu, H.; Caffrey, M., 2000:
Phase behavior of the monoerucin/water system

Wu, J.; Zhou, B.; Hu, Z., 2003:
Phase behavior of thermally responsive microgel colloids

Bechinger, C.; Brunner, M.; Leiderer, P., 2001:
Phase behavior of two-dimensional colloidal systems in the presence of periodic light fields

Palakodaty, S.; York, P., 1999:
Phase behavioral effects on particle formation processes using supercritical fluids

Ecke; Shu; Sullivan; Vilches, 1985:
Phase boundaries and critical and tricritical properties of monolayer 4He adsorbed on graphite

Chui, 1994:
Phase boundaries in ultrathin magnetic films

Fisher; Barbosa, 1991:
Phase boundaries near critical end points. I. Thermodynamics and universality

Barbosa; Fisher, 1991:
Phase boundaries near critical end points. II. General spherical models

Barbosa, 1992:
Phase boundaries near critical end points. III. Corrections to scaling and spherical models

Fujita; Okawa; Matsumoto; Tanaka, 1996:
Phase boundaries of nanometer scale c(2 x 2)-O domains on the Cu(100) surface

Montambaux; Naughton; Chamberlin; Yan; Chaikin; Azbel, 1989:
Phase boundary and magnetization in field-induced spin-density-wave systems

Hu; Huang, 1991:
Phase boundary of a cubic superconducting circuit in a magnetic field of arbitrary magnitude and direction

Yi; Hu, 1992:
Phase boundary of several multicube superconducting circuits in a magnetic field of arbitrary magnitude and direction

Chi; Santhanam; Blöchl, 1990:
Phase boundary of superconducting networks: A new approximation scheme

Rottman, 1990:
Phase boundary of the two-dimensional Ising model with ferromagnetic and antiferromagnetic interactions in a magnetic field

Marcus; Westervelt; Hopkins; Gossard, 1993:
Phase breaking in ballistic quantum dots: Experiment and analysis based on chaotic scattering

Bird; Ishibashi; Ferry; Ochiai; Aoyagi; Sugano, 1995:
Phase breaking in ballistic quantum dots: Transition from two- to zero-dimensional behavior

Moon, S.Joon.; Shattuck, M.D.; Bizon, C.; Goldman, D.I.; Swift, J.B.; Swinney, H.L., 2002:
Phase bubbles and spatiotemporal chaos in granular patterns

Aharonov; Anandan, 1987:
Phase change during a cyclic quantum evolution

Batten, S.R.; Harris, A.R.; Murray, K.S., 2000:
Phase change in tetraphenylphosphonium perchlorate

Wu, J.; Takeda, T.; Toyama, H.; Ajisaka, R.; Masuoka, T.; Watanabe, S.; Sato, M.; Ishikawa, N.; Itai, Y., 1999:
Phase changes caused by hyperventilation stress in spastic angina pectoris analyzed by first-pass radionuclide ventriculography

Liu, Z.; Lai, Y.C.; Hoppensteadt, F.C., 2001:
Phase clustering and transition to phase synchronization in a large number of coupled nonlinear oscillators

Hannon, J.B.; zu Heringdorf, F.J.; Tersoff, J.; Tromp, R.M., 2001:
Phase coexistence during surface phase transitions

Knott, M.; Ford, I.J., 2001:
Phase coexistence in colloidal suspensions: an analytic Poisson-Boltzmann treatment

Moretto; Phair; Ghetti; Tso; Colonna; Skulski; Wozniak; Bowman; Carlin; Chartier; Gelbke; Gong; Hsi; Kim; Lisa; Lynch; Peaslee; Schwarz; de Souza RT; Tsang; Zhu, 1996:
Phase coexistence in multifragmentation?

Stevens; Grest, 1995 :
Phase coexistence of a Stockmayer fluid in an applied field

Rathe; Scully, 1995:
Phase coherence and decoherence in the correlated-spontaneous-emission laser

Kayanuma, 1993:
Phase coherence and nonadiabatic transition at a level crossing in a periodically driven two-level system

Mon; Teitel, 1989:
Phase coherence and nonequilibrium behavior in Josephson junction arrays

Brewer, 1986:
Phase coherence and quantized circulation transitions in superfluid helium

Liu; Giordano, 1990:
Phase coherence and the effect of an ac electric field on the conductance of a disordered one-dimensional system

Gould; Sachrajda; Feng; Delage; Kelly; Leung; Coleridge, 1995:
Phase coherence and trajectory trapping around one or two independently controllable antidots in quantum wires

Schmitteckert; Eckern, 1996:
Phase coherence in a random one-dimensional system of interacting fermions: A density-matrix renormalization-group study

Courtois; Gandit; Pannetier, 1995:
Phase coherence in a two-dimensional array of normal and superconducting wires

Liu; Wu; Tsong, 1992:
Phase coherence in atomic vibration in field dissociation of field desorbed diatomic ions

Miller; Gunaratne; Zou; Davis; Rampersad; Wolfe, 1994 :
Phase coherence in the hysteretic magnetic behavior of parallel Josephson-junction arrays

Sásik; Stroud; Tesanovic, 1995:
Phase coherence in two-dimensional type-II superconductors

Zailer; Frost; Ford; Pepper; Simmons; Ritchie; Nicholls; Jones, 1994:
Phase coherence, interference, and conductance quantization in a confined two-dimensional hole gas

Baer, R.; Neuhauser, D., 2002:
Phase coherent electronics: a molecular switch based on quantum interference

Schumacher, H.W.; Chappert, C.; Crozat, P.; Sousa, R.C.; Freitas, P.P.; Miltat, J.; Fassbender, J.; Hillebrands, B., 2003:
Phase coherent precessional magnetization reversal in microscopic spin valve elements

Reichert; Niering; Holzwarth; Weitz; Udem; Hansch, 2000:
Phase coherent vacuum-ultraviolet to radio frequency comparison with a mode-locked laser

Lera; Nieto-Vesperinas, 1990:
Phase conjugation by four-wave mixing of statistical beams

Saxena; Agarwal, 1985:
Phase conjugation by nondegenerate four-wave mixing with excited-state Zeeman coherences

Sawley, 1988:
Phase conjugation in a moderately dense liquid suspension of microspheres

Freysz; Laffon; Delville; Ducasse, 1994:
Phase conjugation in critical microemulsions

Rogovin, 1985 :
Phase conjugation in liquid suspensions of microellipsoids in the diffusive limit

Rogovin; Sari, 1985:
Phase conjugation in liquid suspensions of microspheres in the diffusive limit

Maki; Davis; Boyd; Sipe, 1992:
Phase conjugation using the surface nonlinearity of a dense potassium vapor

Belic, 1988:
Phase conjugation via multiple gratings in photorefractive crystals

Su, 1995:
Phase considerations in the Thomas-WKB theory: Film structures, quantum wells, and quantum wires

You; Axe; Kan; Hashimoto; Moss; Liu; Crabtree; Lam, 1988:
Phase constitution and thermal expansion of YBa2Cu3O7- delta single crystals

Jones, R.; Pereira, J.; Santoreneos, S.; Vonau, M., 1999:
Phase contrast MRI assessment of thoraco-lumbar spinal cord motion in spinal dysraphism

Markl, M.; Hennig, J., 2001:
Phase contrast MRI with improved temporal resolution by view sharing: k-space related velocity mapping properties

Naidich, T.P.; Altman, N.R.; Gonzalez-Arias, S.M., 1993:
Phase contrast cine magnetic resonance imaging: normal cerebrospinal fluid oscillation and applications to hydrocephalus

Batra, S.; Sen, R.; Jain, K.; Gulati, N., 1995:
Phase contrast microscopic evaluation of placental pathology in premature gestation

Shahi, S.K.; Ranga, S.; Khurana, S.K.; Talib, V.H., 2000:
Phase contrast microscopy: utility in obstetrics and gynaecology

De Graef M; Nuhfer; McCartney, 1999:
Phase contrast of spherical magnetic particles

Sheehy; Walker; DiMauro, 1995:
Phase control in the two-color photodissociation of HD+

Zuo; Bandrauk, 1996:
Phase control of molecular ionization: H2 + and H3 2+ in intense two-color laser fields

Gong, J.; Brumer, P., 2002:
Phase control of nonadiabaticity-induced quantum chaos in an optical lattice

Petrosyan; Lambropoulos, 2000:
Phase control of photoabsorption in optically dense media

Kaminski; Ehlotzky, 1994:
Phase control of scattering resonances in intense bichromatic laser fields

Gerkema, M.P.; Daan, S.; Wilbrink, M.; Hop, M.W.; van der Leest, F., 1993:
Phase control of ultradian feeding rhythms in the common vole (Microtus arvalis): the roles of light and the circadian system

Petrashov; Antonov; Delsing; Claeson, 1995:
Phase controlled conductance of mesoscopic structures with superconducting "mirrors"

Vining, B.A.; Bossio, R.E.; Marshall, A.G., 1999:
Phase correction for collision model analysis and enhanced resolving power of fourier transform ion cyclotron resonance mass spectra

Repp, B.H., 2001 :
Phase correction, phase resetting, and phase shifts after subliminal timing perturbations in sensorimotor synchronization

Schalow, G., 1993:
Phase correlated adequate afferent action potentials as a drive of human spinal oscillators

Björk; Yamamoto, 1988:
Phase correlation in nondegenerate parametric oscillators and amplifiers: Theory and applications

Yevstafiev, V.V., 2001:
Phase density method: a microscopic description of the gas of neutral particles

Protopapas; Knight; Burnett, 1994:
Phase dependence in two-color excitation of a model atom by intense fields

Véniard; Taïeb; Maquet, 1996:
Phase dependence of (N+1)-color (N>1) ir-uv photoionization of atoms with higher harmonics

Schumacher; Weihe; Muller; Bucksbaum, 1994:
Phase dependence of intense field ionization: A study using two colors

Schumacher; Bucksbaum, 1996:
Phase dependence of intense-field ionization

Takahashi; Kawamukai, 2000:
Phase detection of electrostatic force by AFM with a conductive tip

Wang, C.M.; Chao, C.H.; Chang, S.L., 2001:
Phase determination and extension using X-ray multiple diffraction and the maximum-entropy method

Koganezawa, T.; Yoshimura, Y.; Nakamura, N.; Iwasaki, H., 2001 :
Phase determination by wavelength-modulated diffraction. I. Centrosymmetric case

Clinton, 1993:
Phase determination in x-ray and neutron reflectivity using logarithmic dispersion relations

Schmidt; Colella, 1985:
Phase determination of forbidden x-ray reflections in V3Si by virtual Bragg scattering

Roach, J.; Retailleau, P.; Carter, C.W., 2001:
Phase determination via Sayre-type equations with anomalous-scattering data

Voit, 1992:
Phase diagram and correlation functions of the half-filled extended Hubbard model in one dimension

Dünweg; Landau, 1993:
Phase diagram and critical behavior of the Si-Ge unmixing transition: A Monte Carlo study of a model with elastic degrees of freedom

Piercy; De'Bell; Pfnür, 1992:
Phase diagram and critical behavior of the adsorption system O/Ru(001): Comparison with lattice-gas models

Tavares; Telo da Gama MM; Teixeira; Weis; Nijmeijer, 1995:
Phase diagram and critical behavior of the ferromagnetic Heisenberg fluid from density-functional theory

Jacobsen, J.Lykke.; Picco, M., 2002:
Phase diagram and critical exponents of a Potts gauge glass

Bartelt; Einstein; Wille, 1989:
Phase diagram and critical properties of a two-dimensional lattice-gas model of oxygen ordering in YBa2Cu3Oz

Dorneich, A.; Hanke, W.; Arrigoni, E.; Troyer, M.; Zhang, S.C., 2002:
Phase diagram and dynamics of the projected SO(5) symmetric model of high- T(c) superconductivity

Patrick; Chen; Sher, 1987:
Phase diagram and local correlations in pseudobinary alloys

Ceder; Asta; Carter; Kraitchman; de Fontaine D; Mann; Sluiter, 1990:
Phase diagram and low-temperature behavior of oxygen ordering in YBa2Cu3Oz using ab initio interactions

Feng; Seehra, 1992:
Phase diagram and magnetic properties of the diluted fcc system NipMg1-pO

Zhang; Kim; Chan, 1986:
Phase diagram and phase transitions of monolayer and bilayer CF4 on graphite

Mehta, S.K.; Kawaljit, 2002:
Phase diagram and physical properties of a waterless sodium bis(2-ethylhexylsulfosuccinate)- ethylbenzene-ethyleneglycol microemulsion: an insight into percolation

Gompper; Kroll, 1995:
Phase diagram and scaling behavior of fluid vesicles

Althoff; Allen; Wentzcovitch; Moriarty, 1993:
Phase diagram and thermodynamic properties of solid magnesium in the quasiharmonic approximation

Hébert; Caillé; Bel Moufid A, 1993:
Phase diagram at T=0 of the one-dimensional chiral planar model in a twofold-anisotropy field

Raja; Shankar Rao DS; Krishna Prasad S, 1992:
Phase diagram exhibiting a smectic-A-smectic-C-smectic-F meeting point

Kappler; Walker; Luettmer-Strathmann, 1995:
Phase diagram for UPd3 subject to symmetry-breaking stress and magnetic field

Straley; Barnett, 1993:
Phase diagram for a Josephson network in a magnetic field

Parker; Saslow; Gabay, 1991:
Phase diagram for a generalized fully frustrated triangular XY model

Zorzenon dos Santos RM; dos Santos RR, 1988:
Phase diagram for a random mixture of competing Ising anisotropies

Poniewierski; Sluckin, 1991:
Phase diagram for a system of hard spherocylinders

Poole; Essmann; Sciortino; Stanley, 1993:
Phase diagram for amorphous solid water

Zanchi; Bjelis; Montambaux, 1996:
Phase diagram for charge-density waves in a magnetic field

Chen; Cross, 1994:
Phase diagram for coherent vortex formation in the two-dimensional inviscid fluid in circular geometries

Leung; Chandler, 1994:
Phase diagram for excess electrons in simple fluids

Schulte; Holzapfel, 1993:
Phase diagram for mercury up to 67 GPa and 500 K

Bauer; Dietrich, 2000 :
Phase diagram for morphological transitions of wetting films on chemically structured substrates

Maiti; Falicov, 1992:
Phase diagram for sodium clusters

Devereaux; Scalettar; Zimanyi; Moon; Loh, 1995:
Phase diagram for splay glass superconductivity

Kumar; Kurkijarvi; Oja, 1985:
Phase diagram for spontaneous nuclear magnetic ordering in copper

Cruz; Phillips, 1994:
Phase diagram for strongly correlated doped trans-polyacetylene chains

Straley, 1994:
Phase diagram for the Gaudin model

Ariaratnam, J.T.; Strogatz, S.H., 2001:
Phase diagram for the Winfree model of coupled nonlinear oscillators

Kimel; Rikvold; Wang, 1992:
Phase diagram for the antiferromagnetic Blume-Capel model near tricriticality

Matthews; Strogatz, 1990:
Phase diagram for the collective behavior of limit-cycle oscillators

Shrimpton; Joós, 1990:
Phase diagram for the domain-wall lattice of krypton on graphite

Gabay; Garel; Parker; Saslow, 1989:
Phase diagram for the generalized Villain model

Yokota, 1989:
Phase diagram for the infinite-range transverse Ising spin-glass model

Arlett; Whitehead; MacIsaac; De'Bell, 1996:
Phase diagram for the striped phase in the two-dimensional dipolar Ising model

Zaluska-Kotur; Turski, 1990:
Phase diagram for the van der Waals-Potts fluid

Mukamel, E.A.; Shakhnovich, E.I., 2002:
Phase diagram for unzipping DNA with long-range interactions

Xu; Zhang, 1994:
Phase diagram in a two-dimensional Coulomb-gas model

Artuso; Borgonovi; Guarneri; Rebuzzini; Casati, 1992:
Phase diagram in the kicked Harper model

Shalaev, E.Y.; Steponkus, P.L., 1999:
Phase diagram of 1,2-dioleoylphosphatidylethanolamine (DOPE):water system at subzero temperatures and at low water contents

Tiwari; Glaberson, 1990:
Phase diagram of 3He-4He mixture films

Kim; Ma; Chan, 1993:
Phase diagram of 3He-4He mixture in aerogel

Zech; Lee; Keller; Blatter; Kes; Li, 1996:
Phase diagram of Bi2.15Sr1.85CaCu2O8+ delta in the presence of columnar defects

Knebel; Eggert; Engelmann; Viana; Krimmel; Dressel; Loidl, 1996:
Phase diagram of CeCu2(Si1-xGex)2

Lee; Ju; Kim, 1994:
Phase diagram of KH2(P1-xAsx)O4 mixed crystals

Gibaud; Shapiro; Nouet; You, 1991:
Phase diagram of KMn1-xCaxF3 (x<0.05) determined by high-resolution x-ray scattering

Lucarelli, A.; Lupi, S.; Ortolani, M.; Calvani, P.; Maselli, P.; Capizzi, M.; Giura, P.; Eisaki, H.; Kikugawa, N.; Fujita, T.; Fujita, M.; Yamada, K., 2003:
Phase diagram of La2-xSrxCuO4 probed in the infared: imprints of charge stripe excitations

Dahn, 1991:
Phase diagram of LixC6

Dahn; McKinnon, 1985:
Phase diagram of LixMo

Klee; Knorr, 1991:
Phase diagram of N2:Ar:CO solid solutions

Mukamel; Hastings; Corliss; Zhuang, 1985:
Phase diagram of NdSb: Type-I fcc antiferromagnet in a magnetic field

Berg; Beirl; Krishnan; Markum; Riedler, 1996:
Phase diagram of Regge quantum gravity coupled to SU(2) gauge theory

Kitazawa; Nomura; Okamoto, 1996:
Phase diagram of S=1 bond-alternating XXZ chains

Adenwalla; Lin; Ran; Zhao; Ketterson; Sauls; Taillefer; Hinks; Levy; Sarma, 1990:
Phase diagram of UPt3 from ultrasonic velocity measurements

Park; Joynt, 1995:
Phase diagram of UPt3 in the E1g model

Boubcheur; Loison; Diep, 1996:
Phase diagram of XY antiferromagnetic stacked triangular lattices

Kremer; Robbins; Grest, 1986:
Phase diagram of Yukawa systems: Model for charge-stabilized colloids

Lee, J.W.; Cha, M.C.; Kim, D., 2001:
Phase diagram of a disordered boson Hubbard model in two dimensions

Patel; Chen; Kumar, 1993:
Phase diagram of a frustrated smectic liquid-crystal system and the absence of the incommensurate smectic-Ai2 phase

Cannas; Tsallis, 1992:
Phase diagram of a generalized t-J model: Renormalization-group approach

Honjo; Ohta; Matsushita, 1987:
Phase diagram of a growing succinonitrile crystal in supercooling-anisotropy phase space

Dasgupta; Valls, 2000:
Phase diagram of a hard-sphere system in a quenched random potential: A numerical study

Parlinski; Kwiecinski; Urbanski, 1992:
Phase diagram of a hexagonal model with incommensurate phases

Slotte, 1992:
Phase diagram of a lattice microemulsion model in two dimensions

Laradji; Guo; Grant; Zuckermann, 1991:
Phase diagram of a lattice model for ternary mixtures of water, oil, and surfactants

Lin; Shih; Bohanon; Ice; Dutta, 1990:
Phase diagram of a lipid monolayer on the surface of water

Müller, M., 2002:
Phase diagram of a mixed polymer brush

Sengupta; Marx; Nielaba; Binder, 1994:
Phase diagram of a model anticlustering binary mixture in two dimensions: A semi-grand-canonical Monte Carlo study

Alvarez, G.; Mayr, M.; Dagotto, E., 2003:
Phase diagram of a model for diluted magnetic semiconductors beyond mean-field approximations

Santoro; Manini; Parola; Tosatti, 1996:
Phase diagram of a model of correlated hopping of electrons in a lattice of Berry molecules

Christiansen; He; Habip; Bauer; Krueger; Martienssen, 1992:
Phase diagram of a modulated relaxation oscillator with a finite resetting time

Meyer; Anglès d'Auriac JC, 1995:
Phase diagram of a six-state chiral Potts model

Schöll-Paschinger, E.; Levesque, D.; Weis, J.J.; Kahl, G., 2001:
Phase diagram of a symmetric binary fluid in a porous matrix

Veerman; Frenkel, 1990:
Phase diagram of a system of hard spherocylinders by computer simulation

Sebastianes; Figueiredo, 1992:
Phase diagram of a trimodal random surface field

Sebastianes; Figueiredo, 1990:
Phase diagram of a trimodal random-field spin-S Ising model

Liu; Einstein; Sterne; Wille, 1995:
Phase diagram of a two-dimensional lattice-gas model of oxygen ordering in YBa2Cu3Oz with realistic interactions

Chen, S.; Büttner, H.; Voit, J., 2001:
Phase diagram of an asymmetric spin ladder

Aligia; Arrachea; Gagliano, 1995:
Phase diagram of an extended Hubbard model with correlated hopping at half filling

Eggert, S.; Gustafsson, D.P.; Rommer, S., 2001:
Phase diagram of an impurity in the spin-1/2 chain: two-channel Kondo effect versus Curie law

Grousson; Tarjus; Viot, 2001:
Phase diagram of an ising model with long-range frustrating interactions: A theoretical analysis

Folkins; Walker; Chen, 1991:
Phase diagram of betaine calcium chloride dihydrate in an applied electric field

Henkel; Seno, 1996:
Phase diagram of branched polymer collapse

Grumbach; Martin, 1996:
Phase diagram of carbon at high pressures and temperatures

Iota, V.; Yoo, C.S., 2001:
Phase diagram of carbon dioxide: evidence for a new associated phase

Lee; Lee; Kim, 2000:
Phase diagram of congested traffic flow: An empirical study

Troyer; Kontani; Ueda, 1996:
Phase diagram of depleted Heisenberg model for CaV4O9

Brey; Guinea, 2000:
Phase diagram of diluted magnetic semiconductor quantum wells

Ma; Figueiredo, 1996:
Phase diagram of disordered boson systems in the presence of random hopping

Riseborough; Hanggi, 1993:
Phase diagram of doped oxide superconductors: A slave-boson approach

Kapusta, 1990:
Phase diagram of electroweak theory

Zielinska; Mukamel; Steinberg; Fishman, 1986:
Phase diagram of externally modulated Rayleigh-Bénard system near the codimension-two point

Gompper; Kroll, 1994:
Phase diagram of fluid vesicles

Küpfer; Gordeev; Jahn; Kresse; Meier-Hirmer; Wolf; Zhukov; Salama; Lee, 1994:
Phase diagram of flux creep in melt-textured and single-crystalline YBa2Cu3O7- delta

Marenduzzo, D.; Trovato, A.; Maritan, A., 2001 :
Phase diagram of force-induced DNA unzipping in exactly solvable models

Dijkstra, M.; van Roij, R.; Evans, R., 2002:
Phase diagram of highly asymmetric binary hard-sphere mixtures

Clement-Cottuz; Amokrane; Regnaut, 2000:
Phase diagram of highly asymmetric binary mixtures: A study of the role of attractive forces from the effective one-component approach

Kumada, N.; Terasawa, D.; Shimoda, Y.; Azuhata, H.; Sawada, A.; Ezawa, Z.F.; Muraki, K.; Saku, T.; Hirayama, Y., 2002:
Phase diagram of interacting composite fermions in the bilayer nu=2/3 quantum hall effect

Almeida; Mills, 1995:
Phase diagram of magnetic multilayers: The role of biquadratic exchange

Fygenson; Braun; Libchaber, 1994:
Phase diagram of microtubules

Bezryadin; Buzdin; Pannetier, 1995:
Phase diagram of multiply connected superconductors: A thin-wire loop and a thin film with a circular hole

Sfatos; Gutin; Shakhnovich, 1993:
Phase diagram of random copolymers

Bak; Kleban; Unertl; Ochab; Akinci; Bartelt; Einstein, 1985:
Phase diagram of selenium adsorbed on the Ni(100) surface: A physical realization of the Ashkin-Teller model

Chavanis, P.H.; Ispolatov, I., 2002:
Phase diagram of self-attracting systems

Broughton; Li, 1987 :
Phase diagram of silicon by molecular dynamics

Radovic; Ledvij; Dobrosavljevic-Grujic, 1991:
Phase diagram of superconducting-normal-metal superlattices

Bergerhoff; Freire; Litim; Lola; Wetterich, 1996:
Phase diagram of superconductors from nonperturbative flow equations

Antonevych, O.; Forstmann, F.; Diaz-Herrera, E., 2002:
Phase diagram of symmetric binary fluid mixtures: first-order or second-order demixing

Shevchenko, 1994:
Phase diagram of systems with pairing of spatially separated electrons and holes

Fang; Solovyev; Terakura, 2000:
Phase diagram of tetragonal manganites

Brussaard, P.; Fisher, S.N.; Guénault, A.M.; Hale, A.J.; Mulders, N.; Pickett, G.R., 2001:
Phase diagram of the A and B phases of superfluid 3He in aerogel

Yamanaka; Hatsugai; Kohmoto, 1994:
Phase diagram of the Ashkin-Teller quantum spin chain

Chau, H.F.; Wan, K.Y., 2002:
Phase diagram of the Biham-Middleton-Levine traffic model in three dimensions

Rosengren; Lapinskas, 1993:
Phase diagram of the Blume-Emery-Griffiths model on the honeycomb lattice calculated by the cluster-variation method

Tétot; Kudrnovsk; Pasturel; Drchal; Weinberger, 1995:
Phase diagram of the Cu-Pd surface alloy: A first-principles calculation

Motta; Christensen, 1991:
Phase diagram of the Fe1-xCoxSi2 alloy in the fluorite form

Little; Zangwill, 1992:
Phase diagram of the Frenkel-Kontorova-Devonshire model

Coppersmith; Yu, 1989:
Phase diagram of the Hubbard model: A variational wave-function approach

Kaufman; Touma, 1994:
Phase diagram of the Ising model on percolation clusters

Berker; Hui, 1993:
Phase diagram of the Ising model on the square lattice with crossed diagonal bonds

Gocksch; Shen, 1992:
Phase diagram of the N=2 Kazakov-Migdal model

Yamanaka; Hatsugai; Kohmoto, 1993:
Phase diagram of the S=1/2 quantum spin chain with bond alternation

Novais, E.; Miranda, E.; Castro Neto, A.H.; Cabrera, G.G., 2002:
Phase diagram of the anisotropic Kondo chain

Shapira; Klein; Adler; Aharony; Harris, 1994:
Phase diagram of the dilute Ising spin glass in general spatial dimension

Berret; Bostoen; Hennion, 1992:
Phase diagram of the dipolar glass K1-x(NH4)xI

Dongen, 1996:
Phase diagram of the extended Hubbard model at weak coupling

Cannon; Fradkin, 1990:
Phase diagram of the extended Hubbard model in one spatial dimension

Kuroki; Kusakabe; Aoki, 1994:
Phase diagram of the extended attractive Hubbard model in one dimension

Gulácsi; Van Beijeren H; Levi, 1993:
Phase diagram of the five-vertex model

Thijssen, 1989:
Phase diagram of the frustrated XY model on a triangular lattice

Gonnella; Maritan, 1993:
Phase diagram of the frustrated gauge-invariant Ising model

Dagotto; Moreo, 1989:
Phase diagram of the frustrated spin-1/2 Heisenberg antiferromagnet in 2 dimensions

Chubukov; Gagliano; Balseiro, 1992:
Phase diagram of the frustrated spin-1/2 Heisenberg antiferromagnet with cyclic-exchange interaction

Xu; Ting, 1990:
Phase diagram of the frustrated square Heisenberg lattice based upon a modified spin-wave theory

Scalettar; Scalapino; Sugar; Toussaint, 1989:
Phase diagram of the half-filled 3D Hubbard model

Blount; Varma; Aeppli, 1990 :
Phase diagram of the heavy-fermion superconductor UPt3

Shenoy; Gupte, 1988:
Phase diagram of the lattice superconductor

Guerrero; Noack, 1996:
Phase diagram of the one-dimensional Anderson lattice

Tsunetsugu; Sigrist; Ueda, 1993:
Phase diagram of the one-dimensional Kondo-lattice model

Tsuchiizu, M.; Furusaki, A., 2002:
Phase diagram of the one-dimensional extended Hubbard model at half filling

Penc; Mila, 1994:
Phase diagram of the one-dimensional extended Hubbard model with attractive and/or repulsive interactions at quarter filling

Hirsch, 1985:
Phase diagram of the one-dimensional molecular-crystal model with Coulomb interactions: Half-filled-band sector

Ogata; Luchini; Sorella; Assaad, 1991:
Phase diagram of the one-dimensional t-J model

Usadel; Büttner; Kopec, 1991:
Phase diagram of the quantum Ising spin glass in a transverse field

de Souza AM, 1993:
Phase diagram of the quantum anisotropic Heisenberg model on a self-dual hierarchical lattice

Saguia, A.; Boechat, B.; Continentino, M.A., 2002:
Phase diagram of the random Heisenberg antiferromagnetic spin-1 chain

Fisch, 1992:
Phase diagram of the random chiral model

Nowotny, T.; Patzlaff, H.; Behn, U., 2002:
Phase diagram of the random field Ising model on the Bethe lattice

Sebastianes; Saxena, 1987:
Phase diagram of the random-field Ising model with a trimodal distribution

de Oliveira MJ, 1991:
Phase diagram of the spin-1/2 Heisenberg antiferromagnet on a square lattice with nearest- and next-nearest-neighbor couplings

Grollau, S., 2002:
Phase diagram of the spin-3/2 Blume-Capel model in three dimensions

Parlinski, 1993:
Phase diagram of the square-lattice model with 1q and 2q incommensurate modulations

Khachaturyan; Semenovskaya; Morris, 1988:
Phase diagram of the superconducting oxide YBa2Cu3O6+ delta

Barford; Lu, 1991:
Phase diagram of the t-J model: A semiclassical calculation

Houlrik; Jensen, 1986:
Phase diagram of the three-state chiral clock model studied by Monte Carlo renormalization-group calculations

Milman; Hauser; Figueiredo, 1991:
Phase diagram of the transverse Ising model in a random field

Mazzeo; Carlon; van Beijeren H, 1995:
Phase diagram of the two component body-centered solid-on-solid model

Nobre, F.D., 2001:
Phase diagram of the two-dimensional +/-J Ising spin glass

Yi; Zhang; Canright, 1994:
Phase diagram of the two-dimensional Anderson-Hubbard model

Dasgupta; Halley, 1993:
Phase diagram of the two-dimensional disordered Hubbard model in the Hartree-Fock approximation

Scalettar; Loh; Gubernatis; Moreo; White; Scalapino; Sugar; Dagotto, 1989:
Phase diagram of the two-dimensional negative-U Hubbard model

Poilblanc, 1995:
Phase diagram of the two-dimensional t-J model at low doping

Zhitomirsky; Ueda, 1996:
Phase diagram of the unconventional superconductor UPt3 in the weak-crystal-field model

Mirasso; Massidda, 1989:
Phase diagram of the "2+4" model in a mean-field approximation without correlations

Carriço; Camley; Stamps, 1994:
Phase diagram of thin antiferromagnetic films in strong magnetic fields

Abanov; Kalatsky; Pokrovsky; Saslow, 1995:
Phase diagram of ultrathin ferromagnetic films with perpendicular anisotropy

Janz; Lüpke; van Driel HM, 1993:
Phase diagram of vicinal Cu(111) surfaces as determined by second-harmonic generation

Pehlke; Tersoff, 1991:
Phase diagram of vicinal Si(001) surfaces

Tupitsyn; Wallin; Rosengren, 1996:
Phase diagram of vortices in double-layer quantum Hall systems

Parts; Karimäki; Koivuniemi; Krusius; Ruutu; Thuneberg; Volovik, 1995:
Phase diagram of vortices in superfluid 3He-A

Martínez-Miranda; Kortan; Birgeneau, 1987:
Phase diagram, fluctuations, and phase transitions near the liquid-crystal nematic-smectic-A-smectic-C multicritical point

Schulz, 1986:
Phase diagrams and correlation exponents for quantum spin chains of arbitrary spin quantum number

Landau; Binder, 1985:
Phase diagrams and critical behavior of Ising square lattices with nearest-, next-nearest-, and third-nearest-neighbor couplings

Fischer; Furrer; Kaldis; Kim; Kjems; Levy, 1985:
Phase diagrams and magnetic excitations in holmium phosphide

Roussel; Buisine; Maschke; Coqueret; Benmouna, 2000:
Phase diagrams and morphology of polymer dispersed liquid crystals based on nematic-liquid-crystal-monofunctional-acrylate mixtures

Leatherman; Diehl, 1996:
Phase diagrams and rotated incommensurate phases of K, Rb, and Cs adsorbed on Ag(111)

Sarmento; Kaneyoshi, 1993:
Phase diagrams and tricritical behavior of a diluted spin-1 transverse Ising model in a random field

Grushko; Gordon; Vagner; Wyder, 1992:
Phase diagrams at diamagnetic phase transitions

Carneiro; de Mello EV, 1987:
Phase diagrams for 3He-4He and H2-D2 mixtures adsorbed on graphite

Niskanen, 1986:
Phase diagrams for submonolayer films on weakly corrugated substrates

Bowling; Collings; Booth; Goodby, 1993:
Phase diagrams for the blue phases of highly chiral liquid crystals

Balcerzak; Bobák, 1993:
Phase diagrams for the disordered Ising model with second-neighbor interactions

Harris; Aharony, 1989:
Phase diagrams for the randomly diluted resistor network and XY model

Giordano, F.; Rossi, A., 2000:
Phase diagrams in the binary system

Lii; Wang, 1995:
Phase diagrams of a diluted Ising thin ferromagnetic film in a transverse field

Kaneyoshi; Li, 1987:
Phase diagrams of a disordered, ferromagnetic, binary Ising system

Hong; Fultz, 1995 :
Phase diagrams of bcc alloys at low temperatures with ballistic atom movements

Caflisch; Blankschtein, 1986:
Phase diagrams of cubic systems under uniaxial quadratic symmetry-breaking fields

Khusid, B.; Acrivos, A., 2002:
Phase diagrams of electric-field-induced aggregation in conducting colloidal suspensions

Toledano; Figueiredo Neto AM; de Sant'Ana ZA, 2000:
Phase diagrams of lyotropic cholesteric fluids

Lyra; da Silva CR, 1992:
Phase diagrams of magnetically disordered bilayers

Roussel, Fédérick.; Maschke, U.; Buisine, J-Marc.; Coqueret, X.; Benmouna, M., 2002:
Phase diagrams of monomer and uv-cured difunctional-acrylate-nematic-liquid-crystal systems

Dinsmore; Yodh; Pine, 1995:
Phase diagrams of nearly-hard-sphere binary colloids

Zubkus; Tornau; Lapinskas; Kundrotas, 1991:
Phase diagrams of oxygen ordering in high-temperature superconductors RBa2Cu3O7-x

Bauer; Riesenhuber; Geisel, 1996:
Phase diagrams of self-organizing maps

Schaub; Mukamel, 1985:
Phase diagrams of systems exhibiting incommensurate structures

Strandberg, E.; Sparrman, T.; Lindblom, G., 2001:
Phase diagrams of systems with cationic alpha-helical membrane-spanning model peptides and dioleoylphosphatidylcholine

Ni; Iwata, 1995:
Phase diagrams of the Blume-Emery-Griffiths model for semiconducting alloy systems (ABD2)1-x(CD)2x or

Nagai, 1985:
Phase diagrams of the corner cubic Heisenberg model and its site-diluted version on a triangular lattice: Renormalization-group treatment

Zamora; Pérez Alcázar GA; Bohórquez; Rosales Rivera A; Plascak, 1995:
Phase diagrams of the diluted and random-bond Ising model

Sano; Ono, 1995:
Phase diagrams of the electronic state of the one-dimensional d-p model

Goldschmidt; Xu, 1985:
Phase diagrams of the random-field Potts model in three dimensions

Wang; Lee; Kimel, 1987:
Phase diagrams of the spin-1 Ising Blume-Emery-Griffiths model: Monte Carlo simulations

Giamarchi; Lhuillier, 1991:
Phase diagrams of the two-dimensional Hubbard and t-J models by a variational Monte Carlo method

Tejero; Daanoun; Lekkerkerker; Baus, 1994:
Phase diagrams of "simple" fluids with extreme pair potentials

Hirvonen, T.P.; Aalto, H.; Pyykkö, I.; Juhola, M., 1997:
Phase difference of vestibulo-ocular reflex in head autorotation test

Wagner; Brecha; Schenzle; Walther, 1992:
Phase diffusion and continuous quantum measurements in the micromaser

Grondalski, J.; Alsing, P.M.; Deutsch, I.H., 2001:
Phase diffusion as a model for coherent suppression of tunneling in the presence of noise

Blackburn; Gronbech-Jensen, 1996:
Phase diffusion in a chaotic pendulum

D'Alessandro; Politi; Arecchi, 1989:
Phase diffusion in chaotic laser dynamics

Wagner; Brecha; Schenzle; Walther, 1993:
Phase diffusion, entangled states, and quantum measurements in the micromaser

Schwarzer, R., 2002:
Phase discrimination by automated BKD

Schieve; McGowan, 1993:
Phase distribution and linewidth in the micromaser

Vogel; Schleich, 1991:
Phase distribution of a quantum state without using phase states

Hillery; Freyberger; Schleich, 1995:
Phase distributions and large-amplitude states

Brand, 1985:
Phase dynamics for incommensurate nonequilibrium systems

Brand; Wesfreid, 1989:
Phase dynamics for pattern-forming equilibrium systems under an external constraint

Brand, 1985:
Phase dynamics for spiraling Taylor vortices

Brattkus; Misbah, 1990:
Phase dynamics in directional solidification

Fourtune; Rappel; Rabaud, 1994:
Phase dynamics near a parity-breaking instability

Meng; Chai; Zhang, 1992:
Phase dynamics of coherent light in the M-photon Jaynes-Cummings model

Hagberg; Meron; Passot, 2000:
Phase dynamics of nearly stationary patterns in activator-inhibitor systems

Roth; Lücke; Kamps; Schmitz, 1994:
Phase dynamics of patterns: The effect of boundary-induced amplitude variations

Wu; Andereck, 1991:
Phase dynamics of wavy vortex flow

Brand, 1987:
Phase dynamics with a material derivative due to a flow field

Qu; Hu; Yang; Qin, 1995:
Phase effect in taming nonautonomous chaos by weak harmonic perturbations

Bauer; Kastner; Arnau; Salin; Fainstein; Ponce; Echenique, 1992:
Phase effect in the energy loss of H projectiles in Zn targets: Experimental evidence and theoretical explanation

Arnau; Bauer; Kastner; Salin; Ponce; Fainstein; Echenique, 1994 :
Phase effect in the energy loss of hydrogen projectiles in zinc targets

Kasumova, R.J., 2002:
Phase effects at fifth-harmonic generation

Silverans; Borghs; De Bisschop P; Van Hove M, 1985:
Phase effects in bichromatic field interactions with a two-level atom

Fowler, C.G.; Mikami, C.M., 1996:
Phase effects on the middle and late auditory evoked potentials

Kibble; Vilenkin, 1995:
Phase equilibration in bubble collisions

Foffi, G.; McCullagh, G.D.; Lawlor, A.; Zaccarelli, E.; Dawson, K.A.; Sciortino, F.; Tartaglia, P.; Pini, D.; Stell, G., 2002:
Phase equilibria and glass transition in colloidal systems with short-ranged attractive interactions: application to protein crystallization

Umantsev; Olson, 1993:
Phase equilibria and transformations in adiabatic systems

Sokolowska; Moscicki, 2000:
Phase equilibria in an athermal solution of platelike particles

Wnek; Moscicki, 1996:
Phase equilibria in solutions of disklike particles

Wensink, H.H.; Vroege, G.J., 2002:
Phase equilibria in systems of hard disks with thickness polydispersity

Glotova, I.K.; Pavlovskaia, G.E.; Lashko, N.P.; Antonov, I.A.; Tolstoguzov, V.B., 1993:
Phase equilibria in water-defatted milk proteins-carboxymethylcellulose sodium salt systems

Dubey; O'Shea, 1994:
Phase equilibria of Lennard-Jones dipolar plus quadrupolar fluids by Gibbs-ensemble Monte Carlo simulation

Kyu; Chiu, 1996:
Phase equilibria of a polymer-smectic-liquid-crystal mixture

Strange, J.H.; Allen, S.G.; Stephenson, P.C.; Matveeva, N.P., 1996:
Phase equilibria of absorbed liquids and the structure of porous media

Yan, Q.; de Pablo, J.J., 2002:
Phase equilibria of charge-, size-, and shape-asymmetric model electrolytes

Yan, Q.; de Pablo, J.J., 2001:
Phase equilibria of size-asymmetric primitive model electrolytes

Page; Monson, 1996:
Phase equilibrium in a molecular model of a fluid confined in a disordered porous material

Ji, Y.; Heiblum, M.; Sprinzak, D.; Mahalu, D.; Shtrikman, H., 2000:
Phase evolution in a Kondo-correlated system

Carini; Feng; Li; Ruffini, 1992:
Phase evolution of the photon in Kerr spacetime

Jeong, J.H.; Goldenfeld, N.; Dantzig, J.A., 2001:
Phase field model for three-dimensional dendritic growth with fluid flow

Lue; Brenner, 1993:
Phase flow and statistical structure of Galton-board systems

Meingast, C.; Pasler, V.; Nagel, P.; Rykov, A.; Tajima, S.; Olsson, P., 2001:
Phase fluctuations and the pseudogap in YBa(2)Cu(3)O (x)

Orr; Clem; Jaeger; Goldman, 1986:
Phase fluctuations in Josephson junctions

Rauf; Zubairy, 1987:
Phase fluctuations in a degenerate parametric amplifier

Orszag; Saavedra, 1991:
Phase fluctuations in a laser with atomic memory effects

Andersen, J.O.; Al Khawaja, U.; Stoof, H.T.C., 2002:
Phase fluctuations in atomic Bose gases

Peng; Li, 1992:
Phase fluctuations in the Jaynes-Cummings model with and without the rotating-wave approximation

van der Zant HS; Webster; Romijn; Mooij, 1990:
Phase fluctuations in two-dimensional superconducting weakly coupled wire networks

Wienold, J.; Jentoft, R.E.; Ressler, T., 2001:
Phase formation during the decomposition of ammonium heptamolybdate--an in situ XAFS and XRD investigation

Karpe; Larsen; Bottiger, 1992:
Phase formation induced by ion irradiation and electrical resistivity of aluminum-3d-transition-metal alloys

Denier van der Gon AW; Tromp, 1992:
Phase formation sequence and domain structure: A low-energy-electron-microscopy study of the Si(111)-( sqrt 3 x sqrt 3 )Ag surface

Schleich; Bandilla; Paul, 1992:
Phase from Q function via linear amplification

Mobley, C.D.; Sundman, L.K.; Boss, E., 2002:
Phase function effects on oceanic light fields

Dalidovich, D.; Phillips, P., 2002:
Phase glass is a Bose metal: a new conducting state in two dimensions

Scholl, J.F.; Dereniak, E.L.; Descour, M.R.; Tebow, C.P.; Volin, C.E., 2003:
Phase grating design for a dual-band snapshot imaging spectrometer

Brüssler; Metzner; Husemann; Lewerenz, 1988:
Phase identification in the Cu-In-S system by gamma - gamma perturbed angular correlations

Small, J.A.; Michael, J.R., 2001:
Phase identification of individual crystalline particles by electron backscatter diffraction

Love; Scott, 2000:
Phase identification of microfeatures using EPMA methods, especially high-resolution X-ray spectroscopy

Sinha, S.; Oshiro, T.; Sinha, U.; Lufkin, R., 1997:
Phase imaging on a .2-T MR scanner: application to temperature monitoring during ablation procedures

Lakshmi; Swain, 1990:
Phase in the correlated-emission laser

Dai, H.; Nguyen, Q.; Kidd, G.; Feth, L.L.; Green, D.M., 1996:
Phase independence of pitch produced by narrow-band sounds

Micheli-Tzanakou, E.; Pavlopoulos, S., 1997:
Phase information in visual evoked potentials

Chen, Y.; Broschat, S.L.; Flynn, P.J., 1996:
Phase insensitive homomorphic image processing for speckle reduction